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ABSTRACT PAGE
Thyroid hormone receptors (TRa1 and TR|31) are nuclear receptors that bind to 
thyroid hormone to activate or repress target genes involved in metabolism, 
growth, and development. Although primarily found in the nucleus, TRa1 and 
TRp1 rapidly shuttle in and out of the nucleus through nuclear pore complexes. 
Previously, we showed that TRs exit the nucleus through two pathways, termed 
CRM 1-dependent and CRM 1-independent, based on the finding that a potent 
inhibitor of the export factor CRM1 does not fully disrupt TR shuttling. To 
investigate which exportins are involved in the CRM 1-independent pathway, RNA 
interference was used to knockdown expression of several different export 
factors while the effect of knockdown on the nucleocytoplasmic distribution of 
GFP-TRa1 was assessed in live HeLa cells using fluorescence recovery after 
photobleaching (FRAP). Knockdown of exportin 5 and exportin 7, alone and 
together, altered TR’s nuclear export dynamics; recovery was markedly slower in 
photobleached nuclei, indicating that nuclear export was inhibited. To examine 
whether increased nuclear export affects TR-mediated gene expression, we co­
expressed TRa1 or TR(31, exportin 5, and a thyroid hormone response element 
(TRE)-mediated CAT reporter gene. CAT ELISA showed a decrease of TRE- 
mediated CAT reporter gene expression when increased amounts of exportin 5 
were present. Furthermore, we showed that TR subcellular distribution shifts to 
more a cytoplasmic localization when exportin 5 is over-expressed. The 
physiological significance of TR shuttling remains unclear; thus, we sought to 
whether post-translational modification of TR by ubiquitination impacts nuclear 
export. Utilizing immunoprecipitation and western blot analysis, we showed that 
ubiquitinated TR was found primarily in the cytoplasm in the absence T3 and 
bound to chromatin when T3 was present. Thus, our data suggest that TR 
ubiquitination plays a role in T3-mediated gene expression instead of signaling 
TR for nuclear export. Taken together, our data provide evidence that TR 
nuclear export is mediated, in part, by exportin 5 and exportin 7, and that 
disrupting the fine balance between nuclear import and export can lead to 
changes in TR-mediated gene expression. Our findings have general 
implications for the regulation of nuclear export of other members of the nuclear 
receptor superfamily where the misregulation of export may be involved in 
causing cancer or endocrine disease.
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NUCLEAR EXPORT DYNAMICS OF THYROID HORMONE RECEPTORS
CHAPTER 1: GENERAL INTRODUCTION
Thyroid hormone receptors (TR) are part of the nuclear receptor (NR) 
superfamily of ligand-activated transcription factors. Responsible for mediating 
genes involved in metabolism, growth, and development, TRs undergo 
nucleocytoplasmic shuttling. While NRs shuttle in and out of the nucleus through 
nuclear pore complexes, they follow distinct nuclear import and export pathways 
mediated by karyopherins, called importins and exportins, which may be either 
similar or different among NRs in the superfamily. In particular, NRs can follow 
both CRM 1-independent and CRM 1-dependent nuclear export pathways. While 
TRcd has been shown to use a cooperative CRM1/calreticulin-mediated export 
pathway, the CRM1-independent nuclear export pathway remains elusive 
(Grespin et al., 2008; Mavinakere et al., submitted). Calreticulin is a calcium- 
binding protein involved in mediating nuclear export of some NRs (Holaska et al., 
2002; Prufer and Barsony, 2002); in addition, other macromolecules or signals 
may mediate NR nuclear import and export. Previously, post-translational 
modification by phosphorylation has been shown to signal nuclear export of 
some NRs (Shank et al., 2008). While NRs are post-translationally modified with 
ubiquitin to mediate protein degradation and transcription, the impact of NR 
ubiquitination and degradation on nucleocytoplasmic shuttling has not been well 
studied (Dace et al., 2000). Gene regulation can occur at various levels including 
protein shuttling, modification, and degradation. Since TR controls genes 
important for normal cellular function, understanding TR regulation with respect
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to T3-mediated gene expression will help give insight into endocrine disease and 
cancer.
NUCLEAR RECEPTORS
As integral signals of the endocrine system, hormones are circulated 
through the bloodstream to target cells where they bind to their respective 
intracellular nuclear receptors (NRs) or to plasma membrane receptors. With 
currently 49 identified, NRs are ligand-dependent transcription factors for steroids 
or non-steroids and are classified into three major categories known as Type I, 
Type II, and Type III. The latter one is more commonly known as orphan 
receptors. Even though these NRs are considered ligand-activated transcription 
factors, some NRs do not need their ligand to activate transcription.
In their ligand-free state, NRs are seen in three major cellular distributions 
of primarily nuclear, primarily cytoplasmic, or uniform throughout the cell. The 
current understanding is that glucocorticoid receptors (GR) and androgen 
receptors (AR) are found primarily in the cytoplasm and are translocated into the 
nucleus in the presence of their corresponding ligand (Kumar et al., 2006). 
Progesterone receptors (PR), estrogen receptors (ER), and thyroid hormone 
receptors (TR), the subject of this thesis, are all found more commonly in the 
nucleus, while mineralocorticoid receptors (MR) are distributed throughout the 
cell (Kumar et al., 2006).
In general, addition of a ligand causes complete nuclear localization of 
NRs although ligand can also trigger mitochondrial localization of GR, ER, and
3
TR (Kumar et al., 2006). When unliganded GR and AR are found in the 
cytoplasm, they are bound to chaperone complexes including heat shock 
proteins (Hsp70 and Hsp90) and immunophilins (Kumar et al., 2006; Maruvada 
et al., 2003). When ligand is bound and the NR is in its transcriptionally active 
form, a punctate pattern within the nucleus is noted to be an important regulatory 
step marking spatial reorganization of the receptor (Black et al., 2004; Kumar et 
al., 2006). Even though these receptors share structural homology, not all NRs 
behave similarly; thus, each NR within this superfamily is examined individually.
THYROID HORMONE
Thyroid hormone is important in regulating genes responsible for 
metabolism, growth, and development. For example, fibrinogen and other 
proteins involved in the coagulation factor system are under control of thyroid 
hormone, where gene expression is upregulated in the presence of hormone 
(Shih, et al., 2004). Triiodothyronine (T3) and thyroxine (T4) are two forms of the 
hormone that can enter a cell through its plasma membrane by passive diffusion 
like steroid hormones, by facilitated transport, or by binding sites located in the 
membrane (Yen, 2001). Although these two forms do not differ structurally other 
than an additional iodine on T4, T3 and T4 are produced in different tissues at 
different concentrations. T4 is primarily produced by the thyroid gland and is the 
major form of the hormone circulating in the blood system (Waung et al., 2011). 
In the thyroid gland and target cells, T4 is converted to T3 by iodothyronine 
deiodinases, enzymes that remove iodines. While T3 is considered the active
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hormone controlling the major genomic actions within a cell, both T3 and T4 have 
been shown to facilitate genomic or non-genomic effects via a plasma membrane 
receptor (av{33) through classical signal transduction cascades (Davis et al., 
2008).
T3 exerts genomic effects by binding to thyroid hormone receptors (TRs) 
and activating or repressing target genes at thyroid hormone response elements 
(TREs) (Selmi-Ruby and Rousset, 1996). In the absence of T3, TR represses 
transcription at positive TREs and activates transcription at negative TREs. 
Commonly seen as octamer sequences of TAAGGTCA in direct repeats, 
palindromes, or inverted palindromes, TREs are located in regulatory regions of 
DNA and are where TRs can homodimerize or heterodimerize with retinoid X 
receptor (RXR) to control transcription of T3-responsive genes (Burgos-Trinidad 
and Koenig, 1999). In addition, the TR corepressor GRP1 (General Receptor for 
Phophoinositides-1), a nucleotide exchange factor, can decrease TR complex 
formation at TREs, thereby altering positive and negative regulation by T3 (Poirier 
et al., 2005).
Within a cell, T3 is also important in inducing a conformational change in 
TRs. Once the hormone and receptor are bound, a conformational change 
occurs in the receptor at helix 12 in the ligand binding domain so that a new 
surface of the receptor is revealed and promotes transcriptional activity (Selmi- 
Ruby et al., 1998). A corepressor (GRP1, N-CoR, or SMRT) dissociates and a 
coactivator may bind after T3 binds TRs (Bassett et al., 2003; Calkhoven and Ab, 
1996; Horlein et al., 1995). After the coactivator binds to the C-terminal region,
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the complex can promote the transcription of target genes. Other components 
are also associated with the corepressor or coactivator complexes, such as 
histone deacetylases or histone acetyltransferases, respectively (Baumann et al., 
2001; Eckey et al., 2003). With multiple complexes associated with gene 
expression and repression, understanding how TR associates with not only the 
ligand and DNA but also coactivators and corepressors is important in 
understanding its function.
THYROID HORMONE RECEPTORS
Thyroid hormone receptors (TR) a and |3 are encoded by two genes,
THRA and THRB, located on chromosomes 17q11 and 3q24. These genes 
encode for various receptor isoforms that are developmentally regulated as well 
as tissue specific (Jazdzewski et al., 2010; Waung et al., 2011). The TR 
isoforms TRa1, TRa2, TRa3, TR|31, TR(32, and TR|33 arise from alternative 
splicing of the a and (3 gene mRNA transcripts (Selmi-Ruby and Rousset, 1996). 
While TRa1, TR(31, TR(32, and TR|33 are activated when T3 binds, TRa2 and 
TRa3 do not bind thyroid hormone and their functions still remain a mystery 
(Burgos-Trinidad and Koenig, 1999; Jazdzewski et al., 2010). TRa1 and TR|31 
are the two most abundant and widely-expressed isoforms of the receptor and 
are the focus of this thesis. While both TRa1 and TR|31 are expressed in skeletal 
muscle, other tissues express specific TR isoforms. For example, the bone and 
heart largely express TRa1 while the liver expresses primarily TR|31 (Rizzoli et 
al., 1986; Waung et al., 2011). TRa1 and T3 have also been shown to be
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important in skeletal development, as well as bone maintenance (Waung et al., 
2011). Even though TRp1 is very abundant, TRp2 is only found in the pituitary, 
hypothalamus, and developing retina (Selmi-Ruby and Rousset, 1996).
Thyroid Hormone Receptor Domains
TRs are comprised of classical domains that are conserved for both 
steroid and non-steroid NRs: N-terminal transactivation domain, DNA binding 
domain, Hinge region, ligand binding domain, and a variable C-terminal region. 
Between TRcd and TRp1, the N-terminal transactivation domain is the most 
variable; this variability between isoforms is common throughout the NR 
superfamily. In contrast, the DNA binding and ligand binding domains are highly 
conserved throughout the NR superfamily (Sun et al., 2007). The other TR 
isoforms have some similarities and differences in their domains. The N-terminal 
domain of TRcd and TRa2 are identical; however, the C-terminal region of TRa2 
has 120 residues in place of the 40 residues present in TRcd (Burgos-Trinidad 
and Koenig, 1999). In contrast, TRp1 and TRp2 differ in their N-terminal region 
(Selmi-Ruby and Rousset, 1996). Since the N-terminal domain lacks 
conservation within TR isoforms as well as in other members of the NR 
superfamily, it may be important for the selective effects of receptor isoforms 
(Selmi-Ruby et al., 1998).
The N-terminal (A/B) domain contains a region termed AF-1, which has 
transactivation function (Duma et al., 2006). When examining this domain in GR, 
it was found to activate genes even without ligand present. The DNA binding (C) 
domain contains two conserved zinc finger motifs and is also where dimerization
7
occurs. Various localization signals have also been characterized in this domain. 
Poorly conserved throughout the NR superfamily, the Hinge (D) domain was first 
thought to only function to separate the two adjacent conserved domains 
(Nascimento et al., 2006). Current research supports the importance of this 
domain in nuclear export as many NRs, such as AR and GR, have NESs present 
here (Shank, 2008); however, TRcd and TR(31 have a NLS in the Hinge domain, 
not a NES (Mavinakere et al., submitted). The structural feature and folding of 
the Hinge domain in TR has also been implicated in selective TRE recognition 
(Nascimento et al., 2006). Another interesting note is that the Hinge domain of 
PR was found to be important for proteasome-mediated transcription, another 
novel function for NR domains (Tanner et al., 2004). Containing heptad repeats 
important in dimerization for TR, RAR, or RXR, the ligand binding (E) domain 
recognizes and binds hormones and, for GR in particular, can interact with heat 
shock proteins (Selmi-Ruby et al., 1998). An additional transactivation region 
termed AF-2 is found in this domain and is noted to be weaker than AF-1 (Duma 
et al., 2006). NRs have been linked to signal transduction pathways, and MAP 
kinases have been shown to target both the Hinge and ligand binding domains of 
TR to promote transcriptional activity and stabilization (Chen et al., 2003). The 
C-terminal (F) domain is also a variable region within NR isoforms. Overall, each 
NR domain contains multiple functions, thus, exemplifying the complexity of 
studying these proteins. Altough this thesis research focuses on TRs, 
understanding their function has implications for understanding how NRs, in 
general, function as well.
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NUCLEOCYTOPLASMIC SHUTTLING
It was previously thought that TRs were continuously bound to DNA in the 
nucleus; however, current studies have shown that TRs, and other NRs, shuttle 
between the nucleus and cytoplasm (Baumann et al., 2001; Bunn et al., 2001; 
Grespin et al., 2008; Maruvada et al., 2003). This shuttling into and out of the 
nucleus occurs through the nuclear pore complexes (NPCs) of the nuclear 
membrane (Pemberton and Paschal, 2005). Spanning the inner and outer 
nuclear membranes to form diffusion channels, NPCs consist of about 30 
different proteins, known as nucleoporins, arranged in an eight-fold symmetry 
(Elad et al., 2009). Structurally, NPCs have a nuclear basket, a spoke-ring 
complex, and filamentous structures located in the cytoplasm. The pore spans 
about 50 nm in diameter and allows passive transport of proteins up to about 40 
kDa or facilitated transport of larger molecules. Currently, there are several 
different models that describe how macromolecules are transported through the 
NPC; however, one common agreement is that the phenylalanine-glycine repeats 
(FG repeats) located on the nucleoporins are important in the translocation 
process. Transport proteins, known as karyopherins, have the ability to dock at 
these sites to move into the NPC.
Mediating protein shuttling through the pore, importins and exportins are 
karyopherins that recognize proteins by their nuclear localization signals (NLS) 
and nuclear export signals (NES), respectively (Wagstaff and Jans, 2009) (Table 
1). The classical import and export pathways are Ran-mediated, where the Ran- 
GTP concentration gradient pushes the directionality of protein shuttling (Hoelz,
9
Import Cargo
fmportin-a Adaptar protein w.*th importm-pl
importin-p1 Basic residue N'LS cargo. U snRNA 
Glucocorticoid Receptor
Karyophenn-(32
Importin 4
histones, hnRNPAt, ribosomai 
proteins
histories. ribosomai proteins 
Vitamin D Receptor
im ports 5 htstones. nbosomal proteins
lmport*n 7 HIV-1 RTC, ribosomai proteins 
Glucocorticoid Receptor
Importin 8 SRP19. Glucocorticoid Receptor
Importin 9 actm. ribosomai proteins
Importin 11 UbcM2. rpL12
Transportins (1 and 2 ) rir.RNP (import). mRNA export factor 
TAP (in cooperation)
wmmttam?#*
CRM1 Leucine ncri NES cargo.HIV-1 Rev. U 
snRNA. Vitamin D Receptor
Exportin 4 elF5A, Scx2
Exportin 5 tRNA. Pre-miRNAs, 
Androgen Receptor
Exportin 6 act.n profiltn-actin complexes
Exportin 7 pGORhoGAP. 14-3-3o
Table 1. Importins and exportins. Importins and exportins are identified with 
their cargoes. The well-known and well-characterized pathways are importin a/(3 
complex for import and CRM1 for export.
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2011; Weis, 1998) (Fig. 1). In the nucleus, Ran-GTP binding to the importin and 
other components causes the release of the cargo; conversely, Ran-GTP 
promotes exportin binding to cargo (Hood and Silver, 1999; Pemberton and 
Paschal, 2005; Sorokin et al., 2007). Ran-GDP enters the nucleus in association 
with the transport protein NTF2. After export into the cytoplasm, Ran-GTP 
hydrolysis occurring at the cytoplasmic filaments is essential to cause the 
dissociation of the exportin, cargo, and other components (Fig. 1). Both import 
and export are, ultimately, energy-dependent because recycling of importins and 
exportins requires GTP hydrolysis. Karyopherins that mediate the translocation 
of cargo between the nucleus and cytoplasm are also recycled between these 
two compartments in order to facilitate the proper movement of their cargo.
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Im p ortin
Exportin
^  NTF2 
Cargo #
NPC Nucleus
Cytoplasm
Figure 1. Nuclear import and export. RanGTP and RanGDP concentrations 
provide directionality for the nuclear import and export pathways. RanGTP 
promotes nuclear export complex assembly but disassembles nuclear import 
complexes in the nucleus.
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Nuclear Import
A well-characterized nuclear import pathway for a wide array of 
macromolecules utilizes importin a and importin p heterodimeric complexes 
(Kumar et al., 2006; Pemberton and Paschal, 2005). Importin a binds to cargo 
protein containing a NLS with basic residues while importin (3 mediates 
interaction of this cargo complex with the NPC (Fig. 2A). Unlike the importin a/p 
complex, karyopherin p can bind a range of NLSs, such as a sequence with 
basic residues or an arginine-glycine rich sequence (Pemberton and Paschal, 
2005) (Table 1). Structural studies of importins have revealed their flexibility and 
dynamic shape, and may give insight into their ability to translocate a variety of 
cargo into the nucleus (Pemberton and Paschal, 2005; Sorokin et al., 2007). 
Similar to many other cargo, NRs have also been shown to use the classical 
importin a/p pathway. For example, both AR and GR use the importin a/p 
complex for nuclear import while GR also uses importin 7 and importin 8 (Nguyen 
et al., 2009; Pemberton and Paschal, 2005). Recently, we showed that TRa1 
follows two nuclear import pathways mediated by the importin a3/p1 complex or 
by importin 7 (Parente, 2010) (Fig. 2B).
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importin o3
TR Import Model
Figure 2. Nuclear import model. A. Classical import model where an import 
factor, importin, mediates the movement of cargo into the cytoplasm through the 
nuclear pore complex (NPC). Alternatively, importin a is used as an adaptor 
protein to mediate import in a complex with importin [31. B. TR import model 
where import is mediated by importin a3/(31 complex or by importin 7.
Import Model
A
Nucleus
A>
Import receptor / \  
(importin)
Cytoplasm
importin a 
C*rgo
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Nuclear Export
An exportin that has been characterized and extensively examined is 
CRM1 (Chromosome Region Maintenance 1), which shuttles a wide variety of 
cargo containing leucine-rich export signals out of the nucleus (Hutten and 
Kehlenbach, 2007) (Table 1) (Fig. 3A). While the cargo utilizing this classical 
CRM 1-dependent nuclear export pathway has a leucine-rich NES, some nuclear 
receptors, such as TR, appear to lack this sequence but continue to use this 
exportin, in part (Grespin et al., 2008). Steroid nuclear receptors have also been 
shown to use CRM 1-independent nuclear export pathways since their export is 
insensitive to leptomycin B (LMB), a specific CRM1 inhibitor. Interestingly, the 
presence or absence of ligand can also change the nuclear export pathway used. 
For example, VDR export is inhibited by LMB and thus CRM 1-dependent only 
when ligand is not bound (Prufer and Barsony, 2002).
LMB is a well-established reagent commonly used to examine the 
subcellular localization of macromolecules. It is an antifungal antibiotic with 
unsaturated, branched fatty acid chains and a 6-lactone ring that was originally 
shown to inhibit the nuclear export of HIV-1 Rev, which only uses a CRM1- 
mediated export pathway (Hutten and Kehlenbach, 2007; Kudo et al., 1999).
LMB binds CRM1 covalently at a specific cysteine residue (Cys-529), acting as a 
potent inhibitor of the protein (Kudo et al., 1999). This covalent binding of LMB 
to CRM1 specifically blocks interaction of CRM1 with a NES.
Other factors have also been implicated in NR export, such as calreticulin 
(Holaska et al., 2002). Calreticulin is a calcium-binding protein that can be
15
Nucleus
Export Model
Nucleus Cytoplasm
CRM I
CRM 1 -independent pathway
TR Export Model
CRM *> -dependent pathway
Figure 3. Nuclear export model. A. Classical export model where an export 
factor, exportin, mediates the movement of cargo into the cytoplasm through the 
nuclear pore complex (NPC). B. TR export model where two separate pathways 
may be used. CRM1 and calreticulin interact cooperatively to mediate nuclear 
export through the CRM 1-dependent pathway while a novel, uncharacterized 
CRM 1-independent nuclear export pathway can also be used.
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regulated by intracellular levels of calcium ions and is primarily found in the ER 
lumen (DeFranco, 2001; Holaska et al., 2002). However, many researchers 
argue against a role of calreticulin in NR export. This is due to the discovery that 
PEG-induced cell fusion in heterokaryon assays, which are used to study 
nucleocytoplasmic shuttling, caused cytosolic calreticulin levels to increase 
above normal levels (Nguyen et al., 2009). While nuclear export of AR does not 
require calreticulin, TRa1, RXR, VDR, and GR utilize this protein in their nuclear 
export pathways; GR has been shown to use calreticulin independently of CRM 1 
with calreticulin binding directly to its DBD (Grespin et al., 2008; (Holaska et al.,
2002)Nguyen et al., 2009). Although in vitro assays showed that calcium 
stimulated GR nuclear export, in vitro assays with TRa1 showed that increased 
intracellular calcium levels did not change the subcellular localization of TRa1 
(Grespin et al., 2008; Holaska et al., 2002). These findings suggest that calcium 
is essential for GR export but is not the limiting factor for TRa1 export (Grespin et 
al., 2008; Holaska et al., 2002).
Recently, TRa1 has been shown to use a cooperative CRM1/calreticulin- 
mediated export pathway with calreticulin as the adaptor protein essential for 
CRM1 to export TR (Grespin et al., 2008). While TRa1 does not entirely rely on 
CRM1 for export, one study suggests that TR|31 may primarily use a CRM1- 
mediated export pathway (Maruvada et al., 2003). Other studies emphasize that 
TRa1 and TR(31 utilize both CRM 1-dependent and CRM 1-independent nuclear 
export pathways, which is a novel finding for NR export (DeLong et al., 2004;
17
Grespin et al., 2008) (Fig. 3B). This thesis research focuses on identifying the 
exportins mediating the CRM1-independent nuclear export pathway of TR.
Another exportin has recently been discovered as being important for 
mediating the CRM 1-independent nuclear export of AR. Exportin 5 was found to 
use a NES located in the DNA binding and Hinge domains of AR (Shank et al., 
2008). With this finding, exportin 5 involvement in other NRs and, more 
importantly, TR nuclear export will be an important focus for this research since 
NRs have conserved domains and function similarly (Shank et al., 2008).
Nuclear Localization and Nuclear Export Signals
As mentioned previously, macromolecules that move in and out of the 
NPC using karyopherins have signals that determine their subcellular 
localization. These signals are part of their amino acid sequence and are termed 
nuclear localization signals (NLS) and nuclear export signals (NES). By coupling 
mutagenesis and localization studies, NLS and NES sequences have been found 
in conserved domains of steroid and non-steroid NRs. Similar to other NRs, TRs 
have multiple NLS and NES sequences characterized in the Hinge and ligand 
binding domains (Mavinakere et al., submitted; Nguyen et al., 2009; Sorokin et 
al., 2007). However, a novel NLS was found in the N-terminal transactivation 
domain of TRa1 that is not present in TR(31 (Mavinakere et al., submitted).
Classical bipartite NLS sequences consist of basic residues that 
commonly use the importin a/p complex or other alternative importins (Sorokin et 
al., 2007). Depending on the NR, NLS sequences reside in the N-terminal 
transactivation domain, DNA binding domain, Hinge domain, and even the ligand
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binding domain; thus, they are found everywhere. While the classical bipartitie 
NLS spans the DNA binding and Hinge domains of AR, the NLS for ERa and TR 
is found in the Hinge domain (Burns et al., 2011). The DNA binding domain of 
GR and RXR also contains a NLS while GR has an additional NLS characterized 
in the ligand binding domain (Prufer and Barsony, 2002). A second, less defined 
NLS has also been found in the ligand binding domain of AR and GR as well as 
two present in TRs, ligand binding for TRa1 only (Nguyen et al., 2009).
Although a NLS is present in the ligand binding domain of TR, this NLS 
sequence is not fully sufficient for import since a ligand binding domain construct 
(GFP-GST-GFP-LBD) remains cytosolic (Mavinakere et al., submitted).
Classical NES sequences are leucine rich and utilize a CRM 1-mediated 
export pathway. Many NRs, such as ERa, PR, AR, GR, and MR, have this 
sequence in their ligand binding domain (Castoria et al., 2009). However, the 
presence of this leucine rich NES does not gaurantee that the NR will utilize 
CRM1; for example, AR has this NES sequence but only uses CRM1 when its 
ligand is absent (Saporita et al., 2003). While this ligand-dependent NES 
sequence is also found in MR and ER, the NES in AR was found to be both 
necessary and sufficient for cytoplasmic localization of the receptor (Nguyen et 
al., 2009; Saporita et al., 2003). As an exception to this rule, TRs have been 
shown to utilize CRM1 without an identifiable classical NES sequence (Bunn et 
al., 2001)Grespin et al., 2008).
Not only do the number of localization signals vary in NRs and other 
proteins but also the signal strength. The NLS and NES strength and
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accessibility, therefore, aid in determining nuclear export rate of proteins 
(Henderson and Eleftheriou, 2000; Kumar et al., 2006). For example, the well- 
characterized leucine rich NES is greater in strength compared to a novel KNS 
nuclear export signal (Henderson and Eleftheriou, 2000). KNS was first 
characterized from the nuclear export of the hnRNP K protein and consists of 
serines as well as acidic residues. This NES is a CRM1-independent nuclear 
export signal. Taken together, the NLS and NES strength and accessibility may 
be an additional regulatory mechanism for many proteins.
Nucleoporins and Nucleocytoplasmic Shuttling
Nucleoporins have also been indicated as binding partners needed to 
facilitate nucleocytoplasmic shuttling. The Nup214/Nup88 complex consists of 
Nup214 as the cytoplasmic nucleoporin with FG repeats that binds Nup88. 
Previously Nup358, another NPC filamentous protein, was the primary 
nucleoporin thought to bind CRM1; however, current research supports that 
Nup214 plays the major role in binding of CRM1 to mediate protein export 
utilizing this pathway (Hutten and Kehlenbach, 2006). Even though Nup358 is 
implicated in nuclear export, this protein has also been shown to be involved in 
efficient nuclear import of macromolecules utilizing the importin a/p pathway 
(Hutten et al., 2007). Nup1 and Nup2 also have high affinities for import 
complexes, in paricular, importins a and p. Therefore, nucleoporin involvement 
in nucleocytoplasmic shuttling also aid in mediating the dynamic movement of 
macromolecules through NPCs.
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FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING
Fluorescence recovery after photobleaching (FRAP) studies have been 
essential to examine intracellular macromolecule movement within the nucleus or 
between the nucleus and cytoplasm (Deroo et al., 2002; Wang et al., 2004). 
Whether examining macromolecule movement within one compartment or 
between two, live cell imaging coupled with FRAP has been a common technique 
in testing macromolecule movement since the dynamic movement of 
macromolecules cannot be seen at steady-state.
Previous research studying the rapid shuttling of proteins between the 
nucleus and cytoplasm used heterokaryon assays where cells of two cell types 
were fused together in order to examine how the protein moved from one 
nucleus to another (Baumann et al., 2001; DeLong et al., 2004; Maruvada et al., 
2003). This heterokaryon system is no longer beneficial for studying protein 
translocation since, as noted earlier, it has been shown that PEG-induced cell 
fusion causes an increase of cytosolic calreticulin released from the ER lumen 
(Walther et al., 2003). Strong evidence supporting artificial results observed from 
heterokaryon assays is the shuttling of GR; the heterokaryon system causes GR 
to shuttle more rapidly compared to what occurs physiologically (Walther et al.,
2003).
To examine nuclear export and re-import by FRAP, a single cell with two 
or more nuclei is used where one nucleus is subject to high laser power in order 
to irreversibly photobleach a fluorescent protein of interest. Cells with multiple 
nuclei occur in culture with some frequency as a result of nuclear division without
21
cytokinesis. The recovery of fluorescence in the bleached nucleus and loss of 
fluorescence in the unbleached nucleus can then be monitored and analyzed. 
FRAP has also been used to study movement within the nucleus, when 
examining transcriptional activity or protein mobility (Deroo et al., 2002; Kino et 
al., 2004). Both protein movement from the nuclear matrix to chromatin and 
ligand-induced immobilization within the nucleus have been areas of focus 
utilizing FRAP (Deroo et al., 2002). This powerful technique formed an integral 
part of this thesis research.
UBIQUITIN-MEDIATED PROTEASOME PATHWAY
While ubiquitin can mediate protein localization, it is not fully understood 
how ubiquitin-directed protein degradation mediates protein nuclear import and 
export. Named for being a ubiquitous protein important in post-translational 
modification, ubiquitin is attached to proteins in a monomer or poly-chains for 
protein degradation, localization, stabilization, or transcriptional activation (Chen 
and Mallampalli, 2009; Jariel-Encontre et al., 2008). Ubiquitin is a highly 
conserved, 76 amino acid peptide that covalently binds to target proteins as well 
as other ubiquitin proteins to form chains through an ATP-dependent process 
(Fig. 4). Three enzymes are involved in this reversible ubiquitination process. 
First, the E1 ubiquitin-activating enzyme binds the C-terminus of ubiquitin via a 
thioester bond with a cysteine residue on E1; this is an ATP-dependent step.
After activation, ubiquitin is transferred from E1 to the E2 conjugating enzyme by 
another thioester bond. The last enzyme in the cascade is the E3 ubiquitin ligase
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Figure 4. Ubiquitination pathway. Through a series of reactions, ubiquitin is 
attached to target substrate. E1 ubiquitin-activating enzyme primes ubiquitin 
through an ATP-dependent step. Next, E1 transfers ubiquitin to an E2 
conjugating enzyme. The last step is when the E3 ligase transfers ubiquitin to 
the target substrate. A mono-ubiquitin chain can lead to changes in subcellular 
localization or activate or inhibit substrate, while a poly-ubiquitin chain targets 
substrate for proteasome-mediated degradation.
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protein that is important for reaction specificity and binds ubiquitin to the target 
protein. Not surprisingly, several hundred specific E3 ligases have been 
characterized to date (Jariel-Encontre et al., 2008). In some cases, however, 
ubiquitin is attached to target substrates by E2 directly via an isopeptide bond. 
The isopeptide bond occurs between the C-terminus carboxyl group of ubiquitin 
and the amino group of the lysine in target substrates. The polyubiquitin chains 
linked via K29 or K48 can then be recognized by the 26S proteasome for 
degradation (Faus et al., 2005).
Found in both the cytoplasm and nucleus of eukaryotic cells, proteasomes 
are vital macromolecular complexes responsible for maintaining protein turnover 
and degrading over-expressed, misfolded, or non-functional proteins (Jariel- 
Encontre et al., 2008; Kinyamu et al., 2005; von Mikecz, 2006). The 26S 
proteasome holoenzyme is composed of two 19S regulatory subunits comprising 
the lid and base, and one 20S catalytic subunit forming a cylinder-shaped 
structure (Baugh et al., 2009; Jariel-Encontre et al., 2008; Kinyamu et al., 2005). 
The 19S cap recognizes ubiquitinated proteins, utilizes ATP to unfold the protein, 
and then moves the unfolded protein into the proteolytic chamber of the 20S 
subunit where the protein is cleaved into amino acid residues (Baugh et al.,
2009; von Mikecz, 2006).
MG 132 is a potent 26S proteasome inhibitor used in determining if 
proteins utilize the ubiquitin-mediated proteasome degradation pathway 
(Kinyamu et al., 2005). When MG 132 was first used in research, it was 
considered sufficient to show a laddering with higher molecular weight forms of
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the protein by gel electrophoresis to support that it was degraded through this 
pathway. Researchers now know, however, that proteins can have several 
different post-translational modifications such as sumoylation, acetylation, and 
phosphorylation, to name a few. Thus, evidence of direct interactions is needed 
in order to demonstrate unequivocally that a protein is ubiquitinated. This is 
commonly shown with immunoprecipitations.
Nuclear Receptor Degradation
In a ligand-dependent or ligand-independent manner, NRs such as ER, 
AR, GR, and TR are tagged with ubiquitin for degradation through the 
proteasome degradation pathway (Dennis et al., 2001; Deroo et al., 2002; Nawaz 
et al., 1999; von Mikecz, 2006; Wang et al., 2009). NRs have been shown to 
primarily be degraded with the addition of their respective ligand; however, some 
degradation does occur in the absence of ligand (Nawaz et al., 1999). The 
mechanism of NR ubiquitination has also been elucidated with the discovery of 
CHIP (C-terminus of Hsp interacting protein) as the E3 ligase responsible for the 
last step in NR ubiquitination (Faresse et al., 2010). CHIP has been determined 
to be important for ER, AR, and MR ubiquitination and may be important in other 
NR ubiquitination processes since NRs are conserved and use similar 
mechanisms within the cell (Faresse et al., 2010).
Key players involved in the degradation pathway have been shown to 
differ among NRs. For example, ERs use two separate degradation pathways 
depending on the availability of their ligand estrogen (Tateishi et al., 2004). 
Tateishi et al. made the final conclusion that estrogen is an important molecule
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needed to switch between transactivation and degradation of the receptor, which 
are also under control of two independent E3 ligases. Recently, AR has also 
been shown to use these same E3 ligases, MdM2 and CHIP, depending on a 
ligand-dependent phosphorylation event (Chymkowitch et al., 2011). Finally, 
cytosolic MR, which is the inactive form of the receptor, has been shown to be 
preferentially polyubiquitinated by CHIP (Faresse et al., 2010). Current research 
supports that nuclear receptor ubiquitination may occur in two separate 
subcellular locations as well as via two separate pathways.
A variety of signals, including hormone or coactivator binding, 
phosphorylation, and acetylation, prepare a protein for degradation (Nawaz and 
O'Malley, 2004). As more signals for degradation have been revealed, the 
mechanism of ubiquitination and proteasomal degradation has become more 
complex. NR phosphorylation occurring in PEST motifs, comprised of amino 
acid residues Pro, Glu, Ser, and Thr, appears to be the primary signal for 
ubiquitination, as it may signal recognition by ubiquitin enzymes (Kinyamu et al., 
2005). As recognition sites for E2 and E3 enzymes, PEST motifs contain both 
phosphorylation and ubiquitination sites (Duma et al., 2006; Kinyamu et al., 
2005). When a mutation was made in the PEST motif of a GR phosphorylation 
site, both transcriptional activation and protein degradation were inhibited. 
Although GR degradation was affected when the PEST motif was mutated, other 
NRs such as ERa and RXR did not behave similarly with a mutated motif 
(Brunelle et al., 2011). Degradation of PR has also been shown to be controlled 
by phosphorylation through a ligand-dependent mechanism (Nawaz et al., 1999).
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Coactivator binding has also been shown to be another important signal for NR 
degradation (Nawaz et al., 1999).
With NR ubiquitination impacted by multiple signals, ligand binding may be 
the first signal followed by coactivator binding and NR phosphorylation. 
Interestingly, helix 12 of the NR ligand binding domain appears to be tightly 
regulated by these signals. The ligand binds to the receptor to induce a 
conformational change so that coactivators bind directly to this helix 12 region at 
the C-terminal end (Nawaz and O'Malley, 2004). Helix 12 appears to be 
important for ligand-dependent degradation of NRs; mutations in helix 12 of ER 
and RAR, where coactivators are unable to bind, have been shown to prevent 
this hormone-dependent degradation (Nawaz and O'Malley, 2004). The exact 
timeline of events and signals for ubiquitination remains unclear and needs more 
research to understand how each component causes the degradation of NRs. 
Thyroid Hormone Receptor Ubiquitination and Degradation
Currently, research is lacking in the molecular mechanism of TR 
ubiquitination and degradation. T3 has been shown to decrease the half-life of 
the receptor from 4.7 to 3.3 hours as well as reducing TR gene expression 
(Raakat and Samuels, 1981). Although T3 does not promote TR ubiquitination,
T3 has been shown to promote more rapid degradation of TR through the 
ubiquitin-proteasome pathway (Dace et al., 2000; Kenessey and Ojamaa, 2005). 
The ligand binding domain of TRpi has also been shown to be essential in the 
degradation of the protein, which is consistent with other NRs; however, no direct 
interaction between this domain and ubiquitin has been shown (Dace et al.,
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2000; Kenessey and Ojamaa, 2005). Researchers still do not completely 
understand how ubiquitination affects nucleocytoplasmic shuttling of these 
proteins, as some make speculations that are not well supported in the literature. 
Recently, a putative PEST motif was found in TRp1 (from amino acid residues 
211 to 223); however, when the mutation T215A was made, degradation of TR 
was not impacted (Brunelle et al., 2011). This finding was not similar to other NR 
PEST motif involvement in ubiquitination and supports that NRs do not always 
behave similarly. The research from this thesis also focuses on understanding 
TR degradation and ubiquitination with respect to its impact on nuclear export. 
Ubiquitin-mediated Proteasome Pathway and Transcription
The tight coupling of ubiquitin-mediated proteasome degradation and 
transcriptional activation has been a largely studied area of research. The 
relationship and control between these two pathways still remains uncertain; 
however, studies have shown that nuclear receptors bound to DNA are 
ubiquitinated and that ubiquitin pathway enzymes act as coactivators (Nawaz 
and O'Malley, 2004). In a ligand-dependent manner, E2 conjugating enzymes, 
such as UbcH7, and E3 ligases, including E6-associated protein (E6-AP) and 
RPF1/RSP5, have been shown to bind to nuclear receptors at the DNA response 
element to promote transcription (Kinyamu et al., 2005; Nawaz et al., 1999). In 
particular, RPF1 has been shown to enhance ligand-dependent activation of PR 
and GR while E6-AP enhances ER transcription (Kinyamu et al., 2005).
Additional support for the tight coupling of ubiquitination and transcription is the 
finding that deubiquitination enzymes also act as coactivators. The
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deubiquitinating protease USP10 was shown to act as a coactivator for AR 
ligand-dependent transcriptional activation (Faus et al., 2005). These findings 
support that the ubiquitin-mediated proteasome pathway is important for NR 
cycling on DNA response elements and that NR degradation may occur in the 
nuclear matrix (Nawaz and O'Malley, 2004) .
Interestingly, the E3 ligases involved in NR transcriptional activation are 
not the same as the previously mentioned E3 ligases that mediate NR 
ubiquitination (Kinyamu et al., 2005). The E3 ligase MdM2 has been shown to 
be involved in both NR transcriptional activation as well as degradation; although 
MdM2 increases ER transactivation, it has been shown to decrease GR 
transactivation (Kinyamu et al., 2005). Therefore, involvement of ubiquitination in 
transcriptional activation may also differ for each NR and the mechanism 
underlying these differences remains to be discovered. The relationship between 
degradation and transcription also differs between NRs (Deroo et al., 2002). GR 
and ER have been shown to behave differently in the presence of MG 132. With 
a high concentration of MG 132, GR and ER are both seen to have reduced 
mobility within the nucleus; however, at lower MG132 concentration, GR 
transactivation increases while ER transactivation decreases (Duma et al., 2006). 
Proteasome activity has also been shown to be important for AR trancription 
(Tanner et al., 2004). In particular, the Hinge region of AR plays a role in 
proteasome-mediated transcriptional activation; however, the exact mechanism 
still remains unclear (Tanner et al., 2004).
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The proteasome itself has also been linked to transcriptional activation 
(Faus et al., 2005). For example, components of the proteasome complex 
19SRP have been shown to play essential roles in TR-mediated transactivation 
by coordinating the proper loading of liganded TR to a TRE (Satoh et al., 2009). 
With the discovery of proteasome-mediated transcription, a mechanism has been 
proposed where the proteasome may disrupt the preinitiation complex to allow 
elongation to occur for transcription while also aiding in coactivator turnover.
This proposed mechanism is supported by the observation that proteasomes 
accumulate at sites of transcription activity (Faus et al., 2005). Since TRs are 
transcription factors responsible for regulating genes involved in important 
cellular processes, understanding the different levels of transcriptional regulation 
gives insight into the significance of TR shuttling and function, which is a focus of 
this thesis research.
ENDOCRINE DISEASE AND CANCER
NRs have important roles in maintaining normal cells; alterations in these 
receptors that interrupt their normal function have been shown to promote tumor 
proliferation and growth (Cheng, 2003). Receptor mutations may cause reduced 
or aberrant gene expression, reduced DNA or ligand binding ability, or disrupted 
shuttling ability (Cheng, 2003; Black et al., 2004; (Bonamy et al., 2005). For 
example, during prostate cancer disease progression, AR can be imported into 
the nucleus with transcriptional activation occurring when the ligand is not 
present; AR behavior is completely opposite of the receptor’s normal function
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where ligand is needed for both nuclear import and transcription (Pemberton and 
Paschal, 2005). NR mutations have also been associated with other types of 
cancers (Bonamy et al., 2005; DeLong et al., 2004; Hsu and Brent, 1998).
Breast cancer progression and associated endocrine resistance is another 
disease where NR mislocalization, ER in particular, was noted (Castoria et al., 
2009). TRa1 is also involved in nasopharyngeal carcinoma cellular growth 
control (Lee et al., 2002). Lee et al. (2002) proposed that TRa1 acts as a tumor 
suppressor gene in nasopharyngeal carcinoma tumorigenesis. This finding 
supports the importance of NR regulation for normal cellular function.
As previously mentioned with AR and ER, TR mislocalization may also 
impact disease progression. For example, v-ErbA is an oncogenic derivative of 
TRa carried by the avian erythroblastosis virus that causes erythroleukemia and 
sarcoma in chickens (Bonamy et al., 2005; Bunn et al., 2001). The oncoprotein 
has also been shown to cause an altered subcellular distribution of TRa and 
RXR into the cytoplasm (Bonamy et al., 2005). Receptor alterations most 
commonly lead to dominant negative activities (Burgos-Trinidad and Koenig, 
1999; Cheng, 2003).
Mutations in TR|31 can cause Resistance to Thyroid Hormone (RTH) 
syndrome. RTH syndrome is an inherited, autosomal dominant endocrine 
disease where individuals have various mutations found in the TR(31 gene 
(Miyoshi et al., 1998). A link between RTH syndrome and misregulation of TRpi 
nuclear export continues to be examined. With more than 70 mutations seen in 
the TR(31 gene (Privalsky and Yoh, 2000), it is plausible that the
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nucleocytoplasmic shuttling of the receptor is also disrupted. TRp1 has multiple 
localization sequences, and any mutation in the NLS or NES would affect the 
normal physiological shuttling of the receptor as well as impair its function.
THESIS OBJECTIVE
Regulation of TR nuclear export is important in gene expression related to 
homeostasis. Nuclear export of the receptor itself may also be an important 
aspect of gene regulation as seen in the dominant negative effects of v-ErbA on 
TR nuclear distribution. While receptor shuttling has implications in cancer 
development and other thyroid hormone-related diseases, mutated NRs have 
been shown to be present in various cancers such as thyroid, kidney, liver, and 
breast cancer. Finding key players in the nuclear export pathway and 
understanding the physiological significance for this export will help give further 
insight into the regulation of T3-responsive gene transcription, as well as 
implications for other nuclear export pathways that NRs may follow.
The overall aim of this thesis research was to expand knowledge of the 
nucleocytoplasmic shuttling pathway and the significance for export of TRs (a1 
and (31). Currently, TR has been shown to utilize both a CRM 1-dependent and 
CRM 1-independent nuclear export pathway (Grespin et al., 2008; Mavinakere et 
al., submitted). Multiple NESs have been found in TR; two CRM 1-independent 
NESs were characterized in helix 6 and helix 12 of the ligand binding domain 
(Mavinakere et al., submitted). The main objective of this thesis research was to 
determine which exportin(s) mediate the CRM 1-independent nuclear export
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pathway(s) of TR. Another objective was to examine the physiological 
significance of TR nuclear export. TR utilizes the ubiquitin-mediated proteasome 
degradation pathway; however, the compartment in which TR is ubiquitinated 
and degraded is not known. Does TR have to be exported for degradation? 
Thus, in particular, the subcellular localization of ubiquitin-mediated proteasome 
degradation of TR and its impact on nuclear export was examined, as well as the 
impact of thyroid hormone (T3 and T4) availability on nucleocytoplasmic shuttling.
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CHAPTER 2: MANUSCRIPT DRAFT FROM THESIS RESEARCH
EXPORTINS 5 AND 7 MEDIATE THE CRM1-INDEPENDENT 
NUCLEAR EXPORT OF THYROID HORMONE RECEPTORS AND 
LIGAND REGULATES COMPARTMENT-SPECIFIC 
UBIQUITINATION
Kelly S. Subramanian, Hallie N. Nelson, Vinny R. Roggero, Manohara S.
Mavinakere, Lizabeth A. Allison
From the Department of Biology, College of William and Mary
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ABSTRACT
Thyroid hormone receptors (TRa1 and TR(31) are nuclear receptors that 
bind to thyroid hormone (T3) to activate or repress target genes involved in 
metabolism, growth, and development. Although primarily found in the nucleus, 
TRa1 and TR|31 rapidly shuttle in and out of the nucleus through nuclear pore 
complexes. Previously, we showed that TR nuclear export is not completely 
blocked when cells are treated with leptomycin B to inhibit the export factor 
CRM1, suggesting that TR can also exit the nucleus by a CRM1-independent 
pathway. To determine which exportins are involved in the CRM1-independent 
pathway, RNA interference was used to knockdown expression of transports 1, 
transports 2, exportin 4, exportin 5, exportin 6, and exportin 7. The effect of 
knockdown on the nucleocytoplasmic distribution of GFP-tagged TRa1 and TR|31 
was assessed in live HeLa cells using fluorescence recovery after 
photobleaching (FRAP). Knockdown of exportin 5 and exportin 7, alone and 
together, altered the nuclear export dynamics of TR; recovery was markedly 
slower in photobleached nuclei, indicating that nuclear export was inhibited. To 
determine whether increased nuclear export had an impact on TR-mediated 
gene expression, we examined CAT reporter gene expression under control of a 
thyroid hormone response element (TRE) when exportin 5 was overexpressed. 
CAT ELISA showed a decrease of TRE-mediated CAT reporter gene expression 
when increased amounts of exportin 5 were present. Further, we showed that 
when exportin 5 is over-expressed, the distribution of TR shifts to a more 
cytoplasmic localization. To further examine the physiological significance of TR
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nuclear export, we sought to ascertain how TR ubiquitination impacts nuclear 
export. Our data suggest that ubiquitinated TRa1 does not affect nuclear export 
of the receptor; ubiquitinated TR was found primarily in the cytoplasm without T3 
and bound to chromatin when T3 was present. Furthermore, our data provide 
evidence that TR ubiquitination plays a role in T3-mediated gene expression, 
instead of signaling TR for nuclear export. Taken together, our data suggest 
that TR nuclear export is mediated, in part, by exportin 5 and exportin 7, and that 
disrupting the fine balance between nuclear import and export can lead to 
changes in TR-mediated gene expression.
INTRODUCTION
Thyroid hormone (T3) is important in regulating genes responsible for 
metabolism, growth, and development. T3 can enter a cell through the plasma 
membrane by passive diffusion like steroid hormones, by facilitated transport, or 
by binding sites located in the membrane (Yen, 2001). Encoded by two genes, 
THRA and THRB, thyroid hormone receptors (TRa1 and TR(31) respond to T3 
levels by activating or repressing gene expression. Depending on the target 
gene, T 3-responsive transcription may be repressed or activated. In the absence 
of T3, TR represses transcription at positive thyroid hormone response elements 
(TREs) and activates transcription at negative TREs.
As a transcription factor primarily found in the nucleus at steady-state, we 
have previously shown that TRa1 can shuttle between the nucleus and 
cytoplasm (Baumann et al., 2001; Bunn et al., 2001; Grespin et al., 2008). This
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nucleocytoplasmic shuttling occurs through the nuclear pore complexes of the 
nuclear membrane and is mediated by importins and exportins (Pemberton and 
Paschal, 2005).
By coupling mutagenesis and localization studies, nuclear localization 
signal (NLS) and nuclear export signal (NES) sequences have been found in 
conserved domains of steroid and non-steroid nuclear receptors. Similar to other 
nuclear receptors, TRs have multiple NLS and NES sequences characterized in 
the Hinge and ligand binding domains (Mavinakere et al., submitted; Nguyen et 
al., 2009; Sorokin et al., 2007). However, a novel NLS was found in the N- 
terminal transactivation domain of TRa1 that is not present in TRp1 (Mavinakere 
et al., submitted). Previously, we showed that TRa1 uses a cooperative 
CRM1/calreticulin-mediated export pathway (Grespin et al., 2008); however, this 
exact interaction and mechanism remain unclear. Although TRs can follow a 
CRM 1-dependent nuclear export pathway, we know from prior studies that TR 
nuclear export is not completely blocked when cells are treated with leptomycin B 
to inhibit the export factor CRM1, suggesting that TRs can also follow CRM1- 
independent nuclear export pathways. While no CRM1-dependent NES in TRs 
has been characterized, two NES sequences present in helix 6 and helix 12 of 
the ligand binding domain utilize CRM1-indpendent export pathways (Mavinakere 
et al., submitted).
Recently, exportin 5 was shown to be important for mediating the CRM1- 
independent nuclear export of the androgen receptor (AR); through a NES 
located in the DNA binding and Hinge domains of AR (Shank et al., 2008). This
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came as a surprise because exportin 5 was only thought to be involved in 
microRNA biogenesis. With this finding, a role for exportin 5 in the nuclear 
export of other nuclear receptors and, more importantly, TR seemed likely since 
nuclear receptors have conserved domains and function similarly (Shank et al., 
2008).
Despite many studies showing that TR export occurs, the physiological 
significance of this trafficking remains unclear. Some research points to the 
possibility that non-genomic effects, such as signal transduction and TR 
phosphorylation, may promote the nuclear export of TR. Both nuclear export and 
ubiquitination could be mechanisms for regulating T3-mediated genes and thus, 
important in maintaining normal cellular functions. Although T3 does not promote 
TR ubiquitination, T3 has been shown to promote more rapid degradation of TR 
through the ubiquitin-proteasome pathway (Dace et al., 2000; Kenessey and 
Ojamaa, 2005). The ligand binding domain of TR(31 has also been shown to be 
essential in the degradation of the protein, which is consistent with other nuclear 
receptors in the superfamily; however, no direct interaction between this domain 
and ubiquitin has been shown (Dace et al., 2000; Kenessey and Ojamaa, 2005).
Researchers still do not completely understand how ubiquitination affects 
nucleocytoplasmic shuttling of these proteins. PEST motifs, comprised of amino 
acid residues Pro, Glu, Ser, and Thr, target proteins for ubiquitination. Recently, 
a putative PEST motif was found in TR(31 (from amino acid residues 211 to 223); 
however, when the mutation T215A was made, degradation of TR was not 
impacted (Brunelle et al., 2011). This finding differed from other nuclear
38
receptors, where the PEST motif is involved in ubiquitination, suggesting that 
nuclear receptors do not always behave similarly. In prior studies, substrate 
specificity of E3 ligases for nuclear receptors has been shown to be ligand- 
dependent (Chymkowitch et al., 2011; Tateishi et al., 2004). In particular, 
estrogen was shown to be important in switching between transactivation 
function and degradation of the receptor. These processes are under control of 
two different E3 ligases in the nucleus and cytoplasm, respectively.
To determine which exportins are involved in the CRM1-independent 
nuclear export pathway of TR, we coupled RNA interference (RNAi) with in vivo 
FRAP experiments and in vivo overexpression assays. Our data suggest that 
exportins 5 and 7 play a major role in mediating the nuclear export of TRa1. We 
also sought to ascertain whether ubiquitination of TR impacted its nuclear export 
and where ubiquitinated TR was localized in the cell. Immunoprecipitation 
assays showed that in the presence of ligand, ubiquitinated TRa1 was primarily 
nuclear, whereas in the absence of ligand, ubiquitinated TRa1 was found in the 
cytoplasm. Taken together with in vivo FRAP experiments, our data suggest that 
ubiquitination does not trigger TRa1 nuclear export, instead ligand availability 
dictates in which compartment ubiquitination of TR occurs.
METHODS
Plasmids - The plasmid pGFP-TRal encodes a functional GFP-tagged rat TRa1 
fusion protein expressed under human cytomegalovirus promoter control (Bunn 
et al., 2001). pGFP-TR(31 encodes a functional GFP-tagged human TR(31; the
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TR(31 cDNA was cloned into perceiver-M29 vector and was obtained from Capital 
Biosciences. The pGFP-GST-GFP-TRa1 domain construct expression plasmids 
were previously described (Mavinakere et al., submitted).
SureSilencing™ shRNA plasmids were obtained from SABiosciences for 
human transports 1 (TNPOI, KH19196P), transports 2 (TNP02, KH15665P), 
exportin 4 (XP04, KH16763P), exportin 5 (XP05, KH01513P), exportin 6 (XP06, 
KP12791P), exportin 7 (XP07, KP13538P), and a negative control scrambled 
sequence (Qiagen). Four shRNA expression plasmids were designed per target 
gene under control of the U1 promoter and containing a puromycin-resistance 
marker.
pHA-ubiquitin was a gift from K. Fryrear (Eastern Virginia Medical School) 
and encodes hemaglutinum (HA)-tagged ubiquitin. The pkmyc-exportin 5 was 
obtained from Addgene (Addgene plasmid 12552) (Brownawell and Macara, 
2002). pCAT®3-Basic Vector (E1871) was obtained from Promega, and pCMV- 
Myc (631604) was obtained from Clontech. tk-TREp-CAT encodes a synthetic 
TRE linked to a herpes simplex virus thymidine kinase (tk)- chloramphenicol 
acetyltransferase (CAT) fusion gene reporter construct and was a gift from R. 
Evans (Salk Institute for Biological Studies).
Cell Culture - HeLa cells were cultured in Minimum Essential Medium (Gibco), 
supplemented with 10% fetal bovine serum (Invitrogen) and intermittently 
supplemented with penicillin (100 units/mL)/streptomycin (100 pg/mL), at 37°C 
under 5% C 02 and 98% humidity. Cells were grown to 70-90% confluency.
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Transient Transfection and Live Cell Imaging - For transient transfections, cells 
were seeded at 2.0-2.5 x105 cells per 3-cm dish (MatTek Corporation). Twenty- 
four hours after seeding, cells at 70% confluency were transfected with 2 pg 
plasmid DNA and 4 pL of Lipofectamine 2000 Reagent (Invitrogen) in Opti-MEM I 
Reduced Serum Medium (Invitrogen) according to the manufacturer’s protocol. 
Reduced serum medium was replaced with complete medium 9 hours post­
transfection.
Twenty-seven hours after transfection, cells were used for microscopy. 
Prior to imaging, cells were incubated in 2 mL of MEM Alpha medium containing 
100 pg/mL cycloheximide (Sigma), penicillin (100 units/mL)/streptomycin (100 
pg/mL), 10 pg/mL wheat germ agglutinin conjugated to Alexa Fluor® 350 
(Invitrogen), and in some experiments, 2-4 nM LMB (Sigma) or with vehicle 
(methanol) for 30 min. Cells were washed twice with Dulbecco’s phosphate- 
buffered saline (PBS) and imaged. During the experiment, cells were incubated 
in MEM Alpha medium containing 50 pg/mL cycloheximide (Sigma), penicillin (50 
units/mL)/streptomycin (50 pg/mL), and in some experiments, 2-4 nM LMB 
(Sigma), 100 nM T3 or T4 (Sigma), or with vehicle (methanol).
Images were collected from an inverted Nikon A1Rsi Confocal microscope 
Ti-E-PFS using a 40X water objective (Nikon). The 488-nm line of krypton-argon 
laser with a band-pass 525/50 nm emission filter was used for GFP detection 
while the 405-nm line with a band-pass 450/50 emission filter was used for Alexa 
Fluor® 350 detection. Images were obtained using the stimulation/bleaching 
acquisition module of NIS-Elements AR (Nikon).
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FRAP was recorded to analyze shuttling of proteins between nuclei within 
HeLa cells. All FRAP experiments were performed in an OkoLab Incubation 
System for Ti-E PFS-A1 Confocal System at 37°C under 5% C 02 and 37% 
humidity. An initial image was recorded from an area containing a GFP- 
expressing cell with two or more nuclei using 1-4% laser power from the 488 nm 
line and using 8-20% laser power from the 405 nm line. One nucleus within the 
multinucleated cell was exposed at 100% laser power for 10-12 sec using the 
488 nm line. After this bleaching exposure, sequential images were taken every 
5 min for 24 cycles, 2 hours total. To minimize undesired photobleaching, low 
laser intensities of 1-4% of the 488 line were again used for post-bleach images. 
After the 24 cycles, a final image of the cell was recorded from the 488 nm line 
and the 405 nm line. For quantitative analysis of digitized images, fluorescent 
intensity values were generated using NIS-Elements AR (Nikon). Bleached and 
unbleached nuclei were each considered as independent regions of interest. In 
addition, these values took into account the background brightness levels during 
each experiment. Intensity values were subsequently normalized so that the 
total fluorescence within each multinucleated cell after bleaching was equal to 1.
Graphic illustration was used to show the sensitivity of TRa1 
nucleocytoplasmic shuttling. Graphs were generated using Microsoft Excel. The 
mean brightness values for both photobleached and unbleached nuclei were 
plotted as a function of time post-bleach where the fluorescence intensity was 
normalized with the overall fluorescence of bleached and unbleached nucei 
equal to 1.0 (arbitrary units). Similar to the method of analyzing TRa1 shuttling
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kinetics previously published, normalized intensity curves for bleached and 
unbleached nuclei converged towards one another represents the degree of 
fluorescence equilibration between the two (Grespin et al., 2008). Complete 
equilibration when bleached and unbleached nuclei are present occurs at 0.5 
fluorescent units.
Fixation, Immunofluorescence, and Ceil Scoring - HeLa cells were seeded at 2.5-
3.0 x105 cells per well of a 6-well plate with glass coverslips (Fischer). Twenty- 
four hours after seeding, cells were transfected with 2 pg plasmid DNA and 4 pL 
of Lipofectamine 2000 Reagent (Invitrogen) in Opti-MEM I Reduced Serum 
Medium (Invitrogen) according to the manufacturer’s protocol for 7 to 8 hours. 
Approximately 24 to 26 hours post-transfection, cells were fixed in 3.7% 
formaldehyde and permeabilized with 0.2% Triton-X-100. Antibodies used were 
anti-c-Myc at 1:500 (Clontech) and Cy3-goat anti-mouse at 1:500 (Zymed 
Laboratories). After processing, coverslips were mounted onto microscope 
slides in Fluoro-Gel II (Electron Microscopy Sciences) containing the DNA 
counter stain DAPI (4, 6-diamino-2-phenylindole).
Images were analyzed with an inverted Nikon ECLIPSE TE 2000-E 
fluorescence microscope (Sigma, Melville, NY). A Nikon Ultraviolet Excitation: 
UV-2E/C filter block for DAPI visualization, a Blue Excitation: B-2E/C filter block 
for GFP visualization, and a Red Excitation: T-2E/C filter block for Myc 
visualization were used with a Nikon Plan Apo 60X objective. Images were 
collected from an inverted Nikon A1Rsi Confocal microscope Ti-E-PFS using a 
40X water objective (Nikon). NIS-Elements AR software (Nikon) were used for
43
image acquisition and primary image processing. At least 3 replicate 
transfections were performed per experiment, with a minimum of 100 cells 
scored per replicate.
RNA extraction, cDNA synthesis, and Real-time PCR - HeLa cells seeded at 6.0-
7.0 x105 cells per 100-mm dish (Nunc) were transiently transfected with 10 pg 
shRNA plasmid and 20 pL of Lipofectamine 2000 Reagent (Invitrogen) in Opti- 
MEM I Reduced Serum Medium (Invitrogen) according to the manufacturer’s 
protocol. Medium was replaced with complete medium 9 hours post-transfection. 
Twenty-seven hours after transfection, RNA was extracted using the Aurum™ 
Total RNA Mini Kit (732-6820) according to the manufacturer’s specifications for 
cultured mammalian cells (BioRad). The DNase I digest incubation was 
extended to 30 minutes to reduce genomic DNA contamination. To ensure 
quality RNA samples, total RNA was analyzed using the Agilent 2100 
BioAnalyzer. Total RNA samples were run using the RNA 6000 Nano Assay 
according to the manufacturer’s protocol (Agilent Technologies).
600 pg of total RNA was used to synthesize cDNA using the RT2 First 
Strand Kit following the manufacturer’s specifications (C-03, SABiosciences). 
First, each RNA sample was added to a separate Genomic DNA Elimination 
mixture and after, added to a RT cocktail. Quantitative real-time PCR was 
performed using the Real-Time RT2 qPCR Primer Assay following the 
manufacturer’s protocol (SABiosciences) with a reaction mix containing RT2 
Real-Time™ SYBR Green/Fluorescein PCR master mix (PA-011), RNase free 
ddH20, template cDNA, and gene-specific primer. Primers were obtained from
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SABiosciences for specific exportins and an internal control, GAPDH, to 
normalize the raw data. Real-time PCR data were analyzed by the AACt (Livak) 
method using the ABI StepOne Software Version 2.1.
Immunoprecipitation - For immunoprecipitation assays, HeLa cells were 
transfected with 4 pg plasmid DNA and 8 pL of Lipofectamine 2000 Reagent 
(Invitrogen) in Opti-MEM I Reduced Serum Medium (Invitrogen) according to the 
manufacturer’s protocol. Reduced serum medium was replaced with complete 
medium 6 hours post-transfection. Twenty-four hours post-transfection, medium 
was again changed to complete medium. Medium was replaced 12-16 hours 
prior to cell lysing with MEM containing 10% charcoal-dextran stripped FBS 
(Invitrogen) supplemented with or without 100 nM T3 (Sigma) and with or without 
100 nM MG132 (Calbiochem). Cells were rinsed 3 times with D-PBS, scraped, 
and cytoplasmic, soluble nuclear, and chromatin-bound extracts were prepared 
using the Subcellular Protein Fractionation Kit for Cultured Cells (Thermo 
Scientific) according to the manufacturer’s instructions. Whole cell extracts were 
prepared using 1 ml_ lysis buffer (50 mM Hepes pH 7.5, 150 mM NaCI, 10 mM 
NaF, 10% glycerol, 1% NP-40, 5 mM NEM (Sigma), Complete Mini EDTA-free 
Protease Inhibitor Cocktail Tablet (1 tablet/10 mL).
Extracts were incubated with anti-GFP antibody (Santa Cruz) or anti-HA 
antibody (Abeam) for 1 hour at 4°C. Extracts and antibody were then incubated 
with Sepharose Protein G beads (GE Healthcare) rotating for 1.5 to 2 hours at 
4°C. The immunoprecipitated material was washed in lysis buffer and eluted in 
2X SDS-PAGE sample buffer. Samples were separated by 8% SDS-PAGE.
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Replicate Western blots were prepared and probed with anti-Histone 3 (Abeam), 
anti-HA (Abeam), anti-p-tubulin (Santa Cruz Biotechnology Inc.), and anti-GFP 
(Santa Cruz Biotechnology Inc.) antibodies, followed by chemiluminescent 
detection.
Western blotting - The approximate concentration of total protein in whole cell, 
cytoplasmic, soluble nuclear, and chromatin-bound samples was determined by 
Nano Drop (ND-1000 Spectrophotometer). For whole cell and cytoplasmic 
extracts, 40-50 pg of protein were analyzed per lane. Protein amounts to load 
from soluble nuclear and chromatin-bound extracts were determined by 
calculating the equivalent cell amounts compared to the cytoplasmic extracts. 
The samples were separated by 8% SDS-PAGE and transferred to a PVDF 
membrane using the iBIot Dry Blotting System (Invitrogen). The membranes 
were incubated overnight in blocking solution (Tris-buffered saline (TBS), 1% 
bovine serum albumin, 0.1% Tween 20). After 4-6 washes with TBS containing 
0.1% Tween 20, the membranes were incubated with primary antibodies for 1.5 
hours. All antibodies were incubated separately and used with the following 
concentrations: anti-Flistone 3 at 1:5000 (Abeam), anti-HA at 1:7000 (Abeam), 
anti-p-tubulin at 1:200 (Santa Cruz Biotechnology Inc.), anti-GFP at 1:200 (Santa 
Cruz Biotechnology Inc.), or anti-exportin 5 at 1:400 (Abeam). Blots were then 
washed 4-6 times with TBS containing 0.1% Tween 20 and incubated with 
horseradish peroxidase-conjugated goat anti-rabbit IgG (GE Healthcare) at 
1:25,000 for 1.25 hours in blocking solution. Following the incubation, blots were 
washed 6-8 times followed by chemilumiscent detection using ECL Plus or Prime
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detection reagent (GE Healhcare). Protein size was monitored using the Pre- 
Stained Kaleidoscope Protein Standards (BioRad).
CAT Enzyme-Linked Immunosorbent Assay (ELISA) - HeLa cells were plated at
6.0 -7.0 x 105 cells in 100-mm dishes and transiently transfected for 6-7 hours 
with 3.33 pg tk-TREp-CAT reporter plasmid, 3.33 pg GFP-TRa1 or GFP-TR(31 
and 3.33 pg pkmyc or 3.33 pg pkmyc-exportin 5. Cells were also transfected 
with 3.33 pg empty vector (pCAT®3-Basic Vector), 3.33 pg GFP-TRa1, and 3.33 
pg pkmyc as a control. Medium was replaced 12-13 hours post-transfection with 
MEM containing 10% charcoal-dextran stripped FBS (Invitrogen) supplemented 
with or without 100 nM T3. After 12 hours, cells were lysed, cell extracts 
prepared, and extracts were used to determine CAT expression levels by ELISA 
according to the manufacturer’s specifications (Roche Applied Science). Protein 
concentration was determined by Nano Drop (ND-1000 Spectrophotometer) and 
adjusted to the same amount of total protein (600 pg). Microplate modules 
precoated with anti-CAT antibodies were incubated with cell extracts and CAT 
standards. Digoxygenin (DIG)-tagged secondary antibody to CAT was then 
bound to the primary antibody-antigen complex. Bound DIG-tagged antibody 
was quantitated colorimetrically by incubation with peroxidase-conjugated anti- 
DIG and ABTS (2,2’-azino-di-[3-ethylbenzthiazoline sulfonate(6)]) as substrate. 
Washing of microplate modules was performed after each incubation. The 
microplate was read at 405 nm against a reagent blank in a microtiter well 
reader. For each assay, a standard curve utilizing four pure protein standards 
was prepared, to ensure that CAT concentrations of sample extracts fell within
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the linear range of the assay. Replicate samples were assayed in each 
microplate.
RESULTS
TRa1 shuttles more rapidly than TR/S1. Although both TRa1 and TR(31 have 
been shown to shuttle between the nucleus and cytoplasm, only the shuttling 
kinetics of TRa1 have been previously characterized (Grespin et al., 2008).
Here, we used FRAP in multinucleated, transfected HeLa cells to compare the 
kinetics of nuclear export and re-import of GFP-tagged TRa1 and TR(31.
As a control, transfected HeLa cells were incubated before visualization 
with fluorescent-tagged wheat germ agglutinin (WGA), a plasma membrane 
marker; images were taken before and after FRAP experiments to confirm that 
experiments where no shuttling occurred were conducted in a single cell with 
multiple nuclei and not nuclei in adjacent, separate cells. All FRAP experiments 
were also performed in the presence of cycloheximde to ensure that the 
fluorescence recovery of GFP in bleached nuclei was not due to de novo protein 
synthesis.
Within a cell with two or more nuclei, one nucleus was selected and 
exposed to high laser power in order to irreversibly photobleach GFP. The 
unbleached nucleus located in the same cell did not lose fluorescence from the 
high laser power bleaching step (Fig. 1). Fluorescence intensities for bleached 
and unbleached nuclei were monitored with a series of images captured every 5 
minutes post-bleach.
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Consistent with previously reported data (Grespin et al., 2008), TRa1 
recovery of fluorescence to bleached nuclei within live transfected cells was 60% 
(±5%) at 60 min and 75% (±5%) at 120 min (Fig. 1). In contrast, recovery of 
fluorescence to bleached nuclei for TR|31 was measured at 43% (±4%) and 59% 
(±4%) for 60 and 120 min, respectively (Fig. 1). These data are consistent with 
the finding that TR(31 lacks a NLS present in the N-terminal transactivation 
domain of TRa1, which could affect subcellular localization and 
nucleocytoplasmic shuttling (Mavinakere et al., submitted).
CRM1 -independent nuclear export of TRa1 is mediated by exportins 5 and 7. TR 
is rapidly exported from the nucleus and has been shown to utilize both CRM1- 
dependent and CRM 1-independent mediated nuclear export pathways (Bunn, 
Grespin et al., 2008; Mavinakere et al., submitted). To characterize the CRM1- 
independent nuclear export pathway, we coupled in vivo approaches using FRAP 
and RNAi in FleLa cells to examine how knockdown of individual exportins 
impacts the shuttling kinetics of TR. Using the endogenous microRNA 
biogenesis pathway, shRNA expression plasmids have been shown to be 
efficient inducers of RNAi. Here, we used a mix of two shRNA expression 
plasmids per target gene for efficient knockdown. Real-time qPCR validated that 
at least 75% knockdown of target exportin mRNA occurred using shRNA 
expression plasmids (Fig. 2). Since exportin 5 was previously shown to be 
involved in the nuclear export of the androgen receptor, we predicted that 
knockdown of exportin 5 would affect the shuttling of TRa1. HeLa cells were co-
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transfected with GFP-tagged TRa1 and a panel of shRNA expression plasmids 
and analyzed by FRAP.
From plotting the fluorescence intensity data, we were able to determine 
which exportin knockdown affects the dynamic nucleocytoplasmic shuttling of 
TRa1. Since only exportin 5 has been shown to be involved in NR nuclear 
export, we did not expect to see an effect from knockdown of transportins 1 and 
2 or exportins 4, 6, and 7. In particular, transportins 1 and 2 have primarily been 
shown to mediate nuclear import of various unrelated macromolecules as well as 
aiding in mRNA export; therefore, we did not predict that they would be involved 
in TR nuclear export. As expected, knockdown of transports 1 and transports 2 
did not show any change in nuclear export and re-import of TRa1, compared to 
the control where no protein knockdown occurred (Fig. 3). Consistent with 
previously reported data (Grespin et al., 2008), recovery of fluorescence to 
bleached nuclei within live cells transfected with a control shRNA was 52% (±4%) 
at 60 min and 73% (±3%) at 120 min (Fig. 3). Transports 1 and transports 2 
knockdown had similar shuttling kinetics at 60 and 120 min compared with the 
control. Fluorescence recovery to bleached nuclei equilibrations were measured 
at 51% (±6%) and 67% (±5%) for transports 1 and at 54% (±6%) and 68%
(±4%) for transports 2 (Fig. 3). These data suggest that transportins 1 and 2 are 
not involved in TRa1 nuclear export or re-import.
We predicted that knockdown of exportins 4, 6, and 7 would not alter 
TRa1 shuttling kinetics since they have not been shown to be involved in NR 
export. However, exportin 4 did show a slight disruption in nuclear export and re­
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import compared with the control. Fluorescent equilibrations were measured for 
60 min and 120 min at 52% (±4%) and 73% (±3%) for the control and 44% (±2%) 
and 65% (±3%) for exportin 4 (Fig. 4). Further experiments will be required to 
ascertain if exportin 4 is directly involved in TR nuclear export. As predicted, 
knockdown of exportin 6 showed similar shuttling kinetics at 60 and 120 min 
compared to the control, with fluorescent equilibrations to bleached nuclei 
measured at 49% (±4%) and 71 (±4%) (Fig. 4). These data support that 
exportins 4 and 6 do not play a role, or at least not an essential role, in the 
shuttling of TRa1.
Consistent with our hypothesis, exportin 5 knockdown resulted in slower 
nuclear export and re-import compared to the control; fluorescent equilibration 
were measured for 60 min and 120 min at 38% (±2%) and 61% (±3%), 
respectively (Fig. 4). Surprisingly, knockdown of exportin 7 resulted in markedly 
slower shuttling kinetics of TRa1; fluorescent equilibrations were measured for 60 
min and 120 min at 33% (±3%) and 49% (±3%), respectively (Fig. 4). Taken 
together, these data suggest that exportins 5 and 7 are important for the shuttling 
of TRa1, suggesting that both these exportins mediate CRM1-independent 
nuclear export of the receptor.
Since TRs can utilize multiple export pathways, we sought to ascertain 
whether knockdown of expression of multiple exportins involved in the pathway 
further inhibit shuttling kinetics. Nuclear export and re-import of GFP-TRa1 was 
markedly slower when both exportins 5 and 7 were knocked down simultaneouly, 
compared to when exportin 5 or 7 were knocked down alone. Fluorescence
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equilibrations to the bleached nuclei were measured at 30% (±1%) for 60 min 
and 48% (± 3%) for 120 min (Fig. 5). In comparison, when both exportins 5 and 
6 were knocked down, fluorescent recovery in bleached nuclei occurred at 39% 
(±3%) and 60% (±4%) for 60 and 120 min, respectively. Knockdown of both 
exportin 5 and 6 did not further inhibit shuttling compared to exportin 5 
knockdown alone. Taken together with the previous data, our results provide 
strong evidence that both exportins 5 and 7 play important roles in the 
nucleocytoplasmic shuttling of TRa1.
Although knockdown of exportin 5 slowed nuclear export, TRa1 nuclear 
export and re-import was not completely inhibited. Thus, we wanted to test 
whether nuclear export could be further inhibited by enhancing knockdown of 
exportin 5. Since exportin 5 has been shown to be involved in exporting pre­
micro RNA and shRNA from the nucleus (Yi et al., 2005), exportin 5 may have a 
longer half-life, or knockdown of exportin 5 protein levels may need more direct 
approaches. Previously, it was shown that overexpressing exportin 5 in the 
presence of shRNA expression plasmids increased the efficiency of RNAi (Yi et 
al., 2005). Thus, we tested whether, counterintuitively, overexpressing exportin 5 
in the presence of exportin 5 shRNA could enhance knockdown. To this end, we 
analyzed whole cell lysates from HeLa cells transfected with Myc-tagged exportin 
5 and exportin 5 shRNA by western blotting with anti-exportin 5 antibody. When 
knocking down exportin 5, there was only a slight change in exportin 5 protein 
levels compared to the control shRNA, where no knockdown occurred (Fig. 6A).
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In striking contrast, when exportin 5 is overexpressed, there was highly efficient 
knockdown of exportin 5 protein levels with target shRNA.
After determining that efficient knockdown is seen when transfecting with 
Myc-Exp5 expression plasmid and shRNA expression plasmid targeting exportin 
5, we ran parallel FRAP experiments. In comparison to the control and 
knockdown of exportin 5 with shRNA alone, we observed a striking reduction in 
nucleocytoplasmic shuttling of TRa1 (Fig. 6B). The fluorescence equilbrations 
from unbleached nuclei to bleached nuclei were 27% (±1%) at 60 min and 51% 
(±4%) at 120 min. In contrast, as shown earlier HeLa cells transfected with a 
control shRNA expression plasmid showed 52% (±4%) and 73% (±3%) 
fluorescent equilibration from unbleached nuclei at 60 min and 120 min, 
respectively (see Fig. 3). These data support the hypothesis that exportin 5- 
mediated nuclear export is a major pathway followed by TRa1, since the absence 
of this exportin markedly inhibits nucleocytoplasmic shuttling.
Overexpression of exportin 5 promotes nuclear export of TR. Having shown that 
nuclear export of TR is inhibited when exportin 5 is knocked down, we sought to 
test if overexpressing exportin 5 would also alter the subcellular localization of 
TR. Since knocking down exportin 5 caused a decrease in nuclear export of 
TRa1, we hypothesized that overexpressing exportin 5 would increase the 
cytoplasmic localization of TR. To test this prediction, we transiently transfected 
HeLa cells with GFP-TR (a1 or p i)  and Myc-Exp5 (exportin 5) expression 
plasmids, or Myc expression plasmid as a control, and analyzed TR subcellular 
distribution. To score cells that were co-transfected with GFP-TR and the control
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Myc or Myc-Exp5, HeLa cells were immunostained with anti-Myc antibodies (Fig. 
7).
As predicted, TR distribution shifted to a more cytoplasmic localization 
when exportin 5 was overexpressed (p<0.001). Consistent with previous reports 
(Bunn et al., 2001), 90% (±1%) of cells expressing both GFP-TRa1 and Myc 
alone had TRa1 localized to the nucleus, while in the remaing 10% (±1%) of 
cells, TRcd was present primarily in the nucleus with a small cytoplasmic 
population (Fig. 7A). In contrast, 52% (±2%) of cells expressing both GFP- TRcd 
and Myc-Exp5 had TRcd localized to the nucleus, while in the remaining 48% 
(±2%) of cells, TRcd localized to both the nucleus and cytoplasm. Consistent 
with published reports that TR(31 has more of a cytoplasmic population compared 
to TRcd (Baumann et al., 2001), 76% (±2%) cells co-transfected with GFP-TRp1 
and Myc expression plasmids had TRp1 localized primarily to the nucleus with 
the remaining of cells having 24% (±2%) TRpi localized to both the nucleus and 
cytoplasm (Fig. 7B). Similar to the pattern observed with TRcd, 37% (±2%) of 
cells expressing GFP-TRpi and Myc-Exp5 had TRp1 localized in the nucleus 
and 63% (±2%) with TRp1 localized to the nucleus and cytoplasm. For both 
TRcd and TRp1, the percent of cells with cytoplasmic TR increased when 
additional exportin 5 was available for nuclear export. Taken together with 
knockdown experiments, these findings provide additional evidence that exportin 
5 plays a key role in TR nuclear export. These data also show that the 
subcellular localization of TR at steady-state can change dramatically when an 
exportin involved in its nuclear export pathway is overexpressed.
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Enhanced nuclear export of TR decreases T3-mediated gene expression. To 
provide additional insight into the physiological significance of nuclear export, we 
examined the transcriptional activity of GFP-TR (a1 and (31) when 
overexpressing exportin 5 using a CAT reporter under the control of a positive 
TRE (Fig. 8). Since TR is a transcription factor needed in the nucleus for T3- 
mediated genes, we predicted that overexpressing an exportin involved in 
nuclear export of TR would cause a decrease in T3-mediated gene expression. 
HeLa cells were transiently transfected with GFP-TR (a1 or (31) expression 
plasmid, Myc or Myc-Exp5 expression plasmid, and tk-TREp-CAT reporter 
plasmid. Twelve hours after adding 100 nM T3, CAT ELISAs were performed 
using whole cell extracts to determine the CAT protein levels. The levels of CAT 
protein produced were markedly lower in the presence of T3 when exportin 5 was 
overexpressed; CAT protein production was 3-fold lower for GFP-TRa1 and 2- 
fold lower for GFP-TR(31 compared to the controls. Thus, overexpressing 
exportin 5 caused a decrease in T3-responsive gene transcription and directly 
supports a model in which nuclear export of TRs may be an additional level of 
control of TR-mediated gene regulation.
Proteasome inhibition disrupts nuclear export of TR. While TRs are degraded 
through the ubiquitin-mediated proteasome pathway, the subcellular location of 
TR ubiquitination and how ubiquitination impacts nuclear export is not known.
We sought to ascertain whether nuclear export is required for protein turnover.
To investigate the relationship between TRa1 mobility and proteasome-mediated 
degradation, we tested the effect of proteasome inhibition on nuclear export of
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TRa1. HeLa cells were transfected with GFP-TRa1 and incubated with the 
proteasome inhibitor MG132 prior to and during FRAP experiments. MG132 
caused a markedly slower nuclear export and re-import of TRcd, compared with 
shuttling in the absence of MG 132 (Fig. 9). Recovery of fluorescence to 
bleached nuclei in live cells treated with MG132 was measured at 22% (±2%) at 
60 min and 42% (±3%) at 120 min. In contrast, in the absence of MG132, 
recovery to bleached nuclei was measured at 60% (±5%) at 60 min and 75% 
(±5%) at 120 min (Fig. 9). When the proteasome is blocked, the shuttling of 
TRcd was also inhibited, suggesting that an active proteasome is needed for 
normal TR function, in particular nuclear export.
Ubiquitinated unliganded TRa1 localizes to chromatin and the cytoplasm, while 
ubiquitinated liganded TRa1 localizes primarily to chromatin. TR is degraded 
through the ubiquitin-mediated proteasome pathway and is rapidly degraded in 
the presence of T3 (Bondzi et al., 2011; Dace et al., 2000). To investigate the 
localization of ubiquitinated TRcd, we examined cytoplasmic, soluble nuclear, 
and chromatin-bound fractionations of HeLa cells co-transfected with GFP-TRcd 
and HA-Ub (ubiquitin) expression plasmids. Immunoprecipitation and western 
blot analyses were performed with subcellular fractionations to identify where 
ubiquitinated TRcd localizes within the cell. Nuclear Histone H3 and cytoplasmic 
P-tubulin were also examined to ensure fractionations were clean, and samples 
with equivalent cell amounts were analyzed. As shown in Figure 10A, addition of 
MG132 to HeLa cells increased the level of TRcd protein in the soluble nuclear, 
chromatin-bound, and whole cell extracts and increased the level of ubiquitinated
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TRa1 protein in the cytoplasmic, chromatin-bound, and whole cell extracts. 
Consistent with previous research (Dace et al., 2000;(Kenessey and Ojamaa, 
2005), these data support that TR is degraded through the ubiquitin-mediated 
proteasome pathway.
To examine how T3 affected ubiquitinated TR localization, T3 was added 
with MG132 prior to fractionations. When the proteasome was inhibited with 
MG132, ubiquitinated TRa1 was found both in the cytoplasm and bound to 
chromatin (Fig. 10B). When the proteasome was inhibited and T3 was present, 
ubiquitinated TRcd was primarily bound to chromatin (Fig. 10B). Similar to 
previous findings, TRcd was ubiquitinated in the absence and presence of T3, 
indicating that both unliganded and liganded TRcd are degraded through the 
ubiquitin-mediated proteasome pathway. In contrast, the localization of 
ubiquitinated TRcd changed depending on availability of ligand. Since there has 
been a link made between ubiquitination as well as proteasome-mediated 
degradation to transcriptional activation, these data also suggest that 
ubiquitinated liganded TR, may be involved with transcriptional control as it 
remains bound to the chromatin.
Ubiquitination of the Hinge domain of TRcd is ligand-dependent, while 
ubiquitination of the A/B domain, DBD, and LBD do not require ligand. Although 
the ligand binding domain has been shown to be important in TR degradation as 
well as other NRs such as ERa (Dace et al., 2000; (Lonard et al., 2000), the 
ubiquitination sites on TR remain to be elucidated. We first sought to determine 
which TR domain(s) contained putative ubiquitination sites using UbPred, an
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online predictor of potential ubiquitination sites (Fig. 11). TRa1 has four distinct, 
functional domains, A/B domain, DNA binding domain (DBD), Hinge domain, and 
ligand binding domain (LBD). The A/B domain, Hinge domain, and LBD all have 
lysines with high prediction sites for ubiquitination. To investigate which domains 
are in fact ubiquitinated, an in vivo approach was taken with HeLa cells co­
transfected with GFP-GST-GFP- domain constructs and HA-Ub in HeLa cells. 
Twelve to sixteen hours prior to cell lysing, DMSO or MG132 with or without T3 
was added to cells.
First, as a control, we sought to demonstrate that full-length TRa1 and 
ubiquitin interact (Fig. 12A). Consistent with previous research (Dennis et al., 
2001; Kenessey and Ojamaa, 2005), these data show that TRcd is ubiquitinated. 
Next, we examined which TRcd functional domains are ubiquitinated in the 
presence or absence of ligand. In the presence and absence of T3, the A/B 
domain and LBD were both ubiquitinated. The LBD is also supported in the 
literature to be an important domain for mediating TR degradation (Dace et al., 
2000). However, in the absence of T3, the DBD was ubiquitinated, while in the 
presence of T3, the Hinge domain was ubiquitinated (Fig. 12B). For other NRs, 
the A/B domain and LBD have been shown to be important for NR degradation 
due to the transactivation functions present in these domains (AF1 and AF2). 
While previous literature and UbPred do not predict that the DBD can be 
ubiquitinated, we show that the DBD, in fact, can be ubiquitinated in the absence 
of T3. These data provide evidence that all functional domains of TRa1 have 
ubiquitination sites.
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T4 promotes more rapid shuttling of TRa1. T3 has been shown to promote more 
rapid degradation of TR, promote gene expression of T3-mediated genes (at 
positive TREs), and cause a more complete nuclear localization of TR. Since 
ligand is important in genomic and non-genomic functions of TR, we sought to 
ascertain whether T3 and T4 impact the nuclear export of TR. HeLa cells were 
transfected with GFP-TRa1, and cells were incubated prior to and during FRAP 
experiments with 100 nM ligand (T3 or T4). We predicted that T3 would inhibit 
nuclear export since it promotes gene expression, while T4 may promote export 
since it has been linked with signal transduction.
In contrast to our prediction, the addition of T3 did not have a large effect 
on shuttling of TRcd; if anything, there was only a slight decrease in shuttling 
(Fig. 13). Recovery of fluorescence to bleached nuclei within live cells was 
measured at 60 min with 44% (±2%) equilibration and at 120 min with 70% (±2%) 
equilibration (Fig. 13). These results are similar to FRAP experiments in the 
absence of T3, during which TRcd shuttling kinetics were only slightly more rapid: 
recovery to the bleached nuclei was measured at 60% (±5%) equilibration at 60 
min and 75% (±5%) equilibration at 120 min (Fig. 13).
In striking contrast, T4 caused a more rapid nucleocytoplasmic shuttling of 
TRcd, with fluorescence equilibration to bleached nuclei measured at 50% (±2%) 
and 79% (±3%) for 60 and 120 min, respectively (Fig. 13). Our data show that T4 
causes TRcd to shuttle more rapidly between the nucleus and cytoplasm, in 
comparison to not only the control but also to the presence of T3. These findings 
suggest that T4 signals TR for nuclear export and re-import.
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DISCUSSION
Previously we showed that TRcd participates in rapid nucleocytoplasmic 
shuttling and can follow both CRM1-dependent and CRM1-independent nuclear 
export pathways (Bunn et al., 2001; Grespin et al., 2008; Mavinakere et al., 
submitted). Here, we provide evidence for a novel mechanism for the CRM1- 
independent nuclear export pathway of TRs. By coupling in vivo RNAi and FRAP 
experiments, we showed that knockdown of exportin 5 and/or exportin 7 gene 
expression disrupts nuclear export and re-import of TRcd. While knockdown of 
exportin 5 inhibited shuttling kinetics, overexpression of exportin 5 changed TR 
subcellular localization to a more cytoplasmic distribution. We showed that when 
TR localization shifted to a more cytoplasmic distribution, T3-mediated gene 
expression drastically decreased. Taken together, our data provide evidence 
that exportin 5 is important in mediating the nuclear export of TRcd and aids in 
regulating T3-mediated gene expression. From immunoprecipitation and western 
blot analysis, we also showed that TR is ubiquitinated, and that ubiquitinated TR 
in the absence of T3 is found in the cytoplasm but not in the presence of T3. Our 
data support a model in which TR can be degraded via two separate ubiquitin- 
mediated proteasome pathways, and suggest that TRs are ubiquitinated while 
bound to chromatin.
TR isoforms differ in shuttling kinetics
In prior studies, we showed that TRcd shuttles rapidly between the 
nucleus and cytoplasm of HeLa cells and that TRp1 lacks a NLS found in the N- 
terminal domain of TRcd (Grespin et al., 2008; Mavinakere et al., submitted).
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Here, we showed that the shuttling kinetics of TRa1 and TRpi differ; TRa1 
shuttles more rapidly than TRp1. The lack of the additional NLS in TR(31, 
therefore, impacts the shuttling of this receptor. The number and strength of 
signal sequences (NLSs and NESs) differ in the NR superfamily, which is also 
supported by our data. The NLS and NES strength and accessibility, therefore, 
aid in determining the nuclear export rate of proteins (Henderson and Eleftheriou, 
2000; Kumar et al., 2006). These data provide support that the number of signal 
sequences affects the shuttling dynamics of TRs and may also aid in any 
differing behaviors of each isoform.
Exportins 5 and 7 mediate TR nuclear export
While previous research suggests that NRs follow similar nuclear export 
pathways, conflicting data also show that NRs have distinct nuclear export 
behavior. TRcd was previously shown to utilize calreticulin and CRM1 
cooperatively in order to exit the nucleus (Grespin et al., 2008). Other NRs have 
also been shown to use calreticulin and CRM1 such as the glucocorticoid 
receptor (GR); however, some NRs use calreticulin or CRM1 independently of 
each other (Holaska et al., 2002)Nguyen et al., 2009). Recently, AR has been 
shown to utilize exportin 5 in its CRM 1-independent nuclear export pathway 
through interaction with a NES located in the DNA binding domain (Shank et al., 
2008). This is the first exportin other than CRM1 that has been implicated in the 
mechanism of NR export; thus, we predicted that exportin 5 would be involved in 
mediating the nuclear export of TR.
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RNAi utilizes the endogenous mechanism for microRNA bigenesis where 
pri-miRNA is processed to pre-miRNA in the nucleus, exported into the 
cytoplasm through an exportin 5-mediated nuclear export pathway, and further 
matured in the cytoplasm where silencing of genes at the mRNA level occurs. It 
is important to note that exportin 5 is utilized in the process of miRNA and shRNA 
biogenesis, so knocking down this exportin may have widespread effects. In a 
prior study examining shRNA efficiency, exportin 5 overexpression while utilizing 
shRNA for RNAi was shown to cause a more potent knockdown (Yi et al., 2005). 
This approach was taken to further examine exportin 5 knockdown on TR 
shuttling kinetics. Coupled with overexpression experiments, our data support 
the hypothesis that TRa1 can utilize an exportin 5-mediated pathway; this finding 
suggests that exportin 5 may be important for nuclear export of other NRs as 
well.
Surprisingly, we showed that exportin 7 is also a key player in the shuttling 
of TRs. Mediating cargo with folded motifs including basic residues, exportin 7 
was previously shown to bind diverse cargo with variable NESs including elF4A1, 
p50RhoGAP, and14-3-3o. Exportin 7, also known as RanBP16, has been 
described as being similar to CRM1 due to its broad range of cargoes (Mingot et 
al., 2004). With our novel finding, we predict that other NRs in the superfamily 
also utilize this exportin in their nuclear export pathways.
Unliganded TRa1 can be ubiquitinated in the cytoplasm
Our data shed light on the physiological significance of TR nuclear export. 
Continued research has been in the area of post-translational modifications of
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NRs that may direct their subcellular localization. While NR phosphorylation may 
change a protein’s subcellular localization, phosphorylation has also been shown 
as a priming step for signaling ubiquitination (Brunelle et al., 2011). Consistent 
with previous studies, we showed that TR is poly-ubiquitinated and degraded 
through the proteasome-mediated degradation pathway (Bondzi et al.; Dace et 
al., 2000; Kenessey and Ojamaa, 2005).
We show here that ligand-dependent ubiquitination does not fully explain 
the nuclear export dynamics of TRa1. FRAP experiments with GFP-TRa1 
showed that T3 slightly inhibits nuclear export and re-import while 
immunoprecipitation and western blot analysis showed that T3 shifted 
ubiquitinated TR localization to primarily chromatin-bound. Taken together, our 
data suggest that ubiquitination of TR does not substantially direct nuclear 
export; other yet to be identified post-translational modifications may be 
important for mediating nuclear export. Since T3 has been shown to increase 
degradation of TR, presumably if ubiquitination was a factor in TR nuclear export, 
then T3 should drastically increase nuclear export of TR and increase the 
cytoplasmic population of ubiquitinated TR. However, when the proteasome was 
inhibited, TR nuclear export was also impacted. MG132 is commonly used to 
inhibit proteasome-mediated degradation of proteins (Kinyamu et al., 2005); thus, 
it has been a widely used reagent in examining protein degradation. Here, TR 
mobility was drastically impaired and may point to the importance of an active 
proteasome for normal TR function. Other NRs, such as ER and GR, have 
impaired mobility and are localized to the nuclear matrix, therefore, also
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disrupting nuclear export (Deroo et al., 2002). Our findings point to the possibility 
that TR redistributes and becomes associated with the nuclear architecture after 
proteasome inhibition.
Interestingly, the estrogen receptor (ER) has been shown to be 
ubiquitinated in two separate locations by two separate E3 ligases, dependent on 
the presence or absence of ligand (Tateishi et al., 2004). When ERa was not 
bound to estrogen, it was ubiquitinated and bound to CHIP (C-terminus of Hsp 
interacting protein) in its ligand binding domain. As ER is primarily nuclear; the 
finding that CHIP is primarily cytoplasmic suggests that ER must localize to the 
cytoplasm for CHIP-mediated ubiquitination to occur. Taken together with our 
data, a mechanistic model of TR ubiquitination can be proposed. In fact, we 
show that unliganded TRa1 can rapidly shuttle between the nucleus and 
cytoplasm. When unliganded TRcd is in the cytoplasm, some of the receptor 
may be ubiquitinated at that location, supported by our finding that cytoplasmic 
TRcd was ubiquitinated. We also showed that even though liganded TRcd could 
shuttle, the protein was not ubiquitinated in the cytoplasm (Fig. 14). This 
suggests that liganded TRcd was potentially ubiquitinated only in the nucleus.
Our data also suggest that TRcd may have multiple ubiquitin-mediated 
degradation pathways.
Since E3 ligases are the last step important for specificity in the 
ubiquitination process, how E3 ligases regulate the kinetics of NR shuttling would 
be a novel finding. E3 ligases have been seen to regulate and affect the 
localization of proteins. In particular, p53 cellular localization was changed
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depending on MdM2 concentrations (von Mikecz, 2006). MdM2 is a ubiquitously 
localized E3 ligase. Interestingly, when the level of MdM2 was high, then p53 
was poly-ubiquitinated in the nucleus and degraded while low levels caused 
mono-ubiquitination and nuclear export of p53 (von Mikecz, 2006).
TRa1 ubiquitination occurs in a ligand-independent and ligand-dependent 
manner
As multifaceted proteins, various regions of NRs have been implicated in 
their ubiquitination and degradation. The transactivating regions found in the N- 
terminal and ligand binding domains of NRs have been shown to be important in 
ubiquitination (Duma et al., 2006). While ER is ubiquitinated in both regions, the 
ligand binding domain of TR(31 appears to be important for the degradation of the 
protein (Dace et al., 2000). Our data suggest that all of the domains have 
potential ubiquitination sites depending on the presence of ligand. The N- 
terminal and ligand binding domains of TR can be constitutively ubiquitinated, 
which means they are ubiquitinated no matter whether the ligand is present or 
not. In contrast, ubiquitination of the DNA binding and Hinge domains occur in a 
ligand-independent or ligand-dependent manner. While the DNA binding domain 
has not been implicated in NR ubiquitination, the DNA binding domain of p53 has 
been shown to have multiple ubiquitination sites (Chan et al., 2006). Another 
interesting note is that the Hinge domain of PR was found to be important for 
proteasome-mediated transcription, another novel function for NR domains 
(Tanner et al., 2004). While our data show that the Hinge domain is 
ubiquitinated in the presence of ligand, our data point to the possibility that the
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Hinge domain of TR may also be involved in proteasome-mediated transcription. 
A limitation of our findings is that we examined the domains separately and did 
not look at the full-length protein, which may play a factor in what Lys residues 
are, in fact, ubiquitinated. Since we only tested the domains, examining the full- 
length protein with mutagenesis analysis would give more information on what 
domains may work together or how other physiological signals within the cell may 
affect ubiquitination.
Conclusion
In summary, the results presented here reveal the complexity of TR 
shuttling, which uses multiple pathways and provides further evidence for CRM1- 
independent nuclear export of TR. The mechanistic detail and physiological 
significance of nuclear export remain to be elucidated for proteins found primarily 
in the nucleus at steady-state. The challenge of studying these proteins is 
evident in their localization, since their nuclear export is rapid and transient. 
Determining the physiological significance of TR nuclear export is an important 
area of research as T3-mediated gene expression is highly sensitive to TR 
localization changes. With the discovery of two CRM1-indpendent NESs in the 
ligand binding domain of TR (Mavinakere et al., submitted), continued in vivo 
experiments will be needed to determine the exportins that can bind to these 
NESs and under what cellular conditions. Insight in determining where these 
exportins bind would not only reveal additional information for the nuclear export 
mechanism of other members of the NR superfamily but would also aid in 
determining the NES sequence these exportins bind in other cargoes. The
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finding that TRs can use multiple export pathways also deomonstrates that 
nuclear export is required for normal TR function. As a whole, these data provide 
insight into the mechanism and physiological significance of TR nuclear export 
and therefore, T3-mediated gene expression.
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Figure 1. TRp1 shuttles markedly slower than TRa1. HeLa cells were 
transiently transfected with GFP-TR (a1 or p1) expression plasmid. FRAP 
experiments were performed in multinucleated live cells to monitor the movement 
of GFP-TR from unbleached to bleached nuclei (n=4, TRa1; n=4, TRp1). In 
order to identify cells with two or more nuclei, HeLa cells were incubated before 
visualization with wheat germ agglutinin (WGA), a plasma membrane marker, 
with images taken before and after each experiment. Fluorescence recovery 
graphs showing the relative movement of GFP-TR in and out of the nuclei were 
generated. Green diamonds represent relative fluorescence intensity within 
unbleached nuclei, while red squares represent intensity within bleached nuclei. 
Error bars indicate SEMs.
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Figure 2. shRNA knockdown of target gene mRNA. HeLa cells were 
transiently transfected with a panel of shRNA expression plasmids. Twenty- 
seven hours post-transfection, cells were lysed and RNA extracted, cDNA was 
synthesized, and then real-time PCR was performed. The relative quantity (RQ) 
of target gene mRNA expression was determined by the AACt (Livak) method. 
GAPDH was used as an internal control to normalize the raw data. A control 
shRNA expression plasmid, where no mRNA knockdown occurred, was also 
used, as indicated on the graph (RQ=1). Knockdown of target gene mRNA was 
at least 75% with shRNA expression plasmids. Error bars indicate SEMs. 
(Control, control shRNA; T1, transports 1; T2, transports 2; X4, exports 4; X5, 
exports 5; X6, exports 6; X7, exports 7)
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Figure 3. Knockdown of transportin 1 or transportin 2 does not disrupt 
shuttling of TRa1. HeLa cells were transiently transfected with GFP-TRa1 
expression plasmid and shRNA expression plasmid targeting transportin 1 (T1 
shRNA) or transportin 2 (T2 shRNA). Parallel experiments were run with a 
control shRNA expression plasmid (Control shRNA), where no protein 
knockdown occurs. FRAP experiments were performed in multinucleated live 
cells to monitor the movement of GFP-TRa1 from the unbleached to the 
bleached nuclei (n=7, Control shRNA; n=6, T1 shRNA; n=6, T2 shRNA). 
Fluorescence recovery graphs show the shuttling of GFP-TRa1 with red squares 
indicating relative intensity within bleached nuclei and green diamonds indicating 
relative intensity within unbleached nuclei. Error bars indicate SEMs.
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Figure 4. Nuclear export and re-import of TRa1 is disrupted by knockdown 
of exportin 5 and exportin 7. HeLa cells were transiently transfected with GFP- 
TRa1 expression plasmid and shRNA expression plasmid targeting exportins 4, 
5, 6, or 7 (X4, X5, X6, or X7 shRNA). A control shRNA expression plasmid 
(Control shRNA) was also used, where no protein knockdown occurs. 
Nucleocytoplasmic shuttling of TRcd was monitored through FRAP (n=7, Control 
shRNA; n=7, X4 shRNA; n=9, X5 shRNA; n=7, X6 shRNA; n=9, X7 shRNA). The 
relative shuttling of GFP-TRa1 is indicated in the fluorescence recovery graphs 
where red squares are the intensity within bleached nuclei and green diamonds 
are the intensity within unbleached nuclei. Error bars indicate SEMs.
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Figure 5. Knockdown of both exportins 5 and 7 results in markedly slower 
shuttling kinetics of TRa1. HeLa cells were transiently transfected with GFP- 
TRa1 expression plasmid and shRNA expression plasmid targeting exportins 5 
and 6 (X5 & X6 shRNA) or exportins 5 and 7 (X5 & X7 shRNA). FRAP 
experiments were performed to monitor the movement of GFP-TRa1 from the 
unbleached to the bleached nuclei (n=6, X5 & X6 shRNA; n=6, X5 & X7 shRNA). 
Fluorescence recovery graphs indicate the shuttling of GFP-TRa1 with red 
squares representing the relative intensity within bleached nuclei and green 
diamonds representing the relative intensity within unbleached nuclei. Error 
bars indicate SEMs.
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Figure 6 . Combined overexpression of exportin 5 and targeting exportin 5 
with shRNA leads to highly efficient knockdown of exportin 5 and disrupts 
the shuttling of TRa1. A. To determine knockdown of exportin 5 protein levels, 
HeLa cells were transiently transfected with GFP-TRa1 expression plasmid, Myc- 
tagged exportin 5 (Myc-Exp5) expression plasmid, Myc expression plasmid as a 
control, and shRNA expression plasmid targeting exportins 5 (X5 shRNA). 
Whole cell extracts were subject to Western blot analysis using anti-Exp5 
antibodies and anti-P-tubulin antibodies, as a loading control. Bio-Rad pre­
stained Kaleidoscope protein molecular mass standards were used to confirm 
protein identity (Exp5, 136 kDa; p-tubulin, 55 kDa). B. To determine how this 
highly efficient exportin 5 knockdown affected shuttling of TRa1, HeLa cells were 
transfected with GFP-TRa1 expression plasmid, Myc-Exp5 expression plasmid, 
and X5 shRNA expression plasmid. FRAP experiments were performed to 
monitor the nucleocytoplasmic shuttling of GFP-TRa1 (n=4). A fluorescence 
recovery graph indicating the shuttling of GFP-TRa1 was generated. Green 
diamonds represent relative fluorescence intensity within unbleached nuclei, 
while red squares represent intensity within bleached nuclei. Error bars indicate 
SEMs.
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Figure 7. Overexpression of exportin 5 promotes nuclear export of TR. A.
HeLa cells were transiently transfected with GFP-TRa1 expression plasmid and 
Myc or Myc-Exp5 expression plasmid. After 17-19 hours, cells were fixed, 
immunostained with anti-Myc antibodies (red) and analyzed by fluorecence 
microscopy. Nuclei were stained for DNA with DAPI (blue). Bar graph 
summarizes the effect of overexpressing exportin 5 on TRcd distribution in two 
categories; nuclear (N), nuclear and cytoplasmic (N + C). Error bars represent 
SEMs. Chi-square, p<0.001 (n=4 with 3 replicates each, at least 100 cells per 
replicate) B. Parallel experiments were performed with HeLa cells transfected 
with GFP-TR(31 expression plasmid and Myc or Myc-Exp5 expression plasmid. 
Bar graph summarizes the effect of overexpressing exportin 5 on TRp1 
subcellular distribution. Error bars represent SEMs. Chi-square, p<0.001 (n=3, 3 
replicates each, at least 100 cells per replicate)
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Figure 8 . Overexpression of exportin 5 decreases TR-mediated gene 
expression. A. Exportin 5 was overexpressed in HeLa cells. Whole cell 
extracts of cells transfected with Myc or Myc-Exp5 expression plasmid were 
subject to Western blot analysis using anti-Exp5 and anti-(3-tubulin antibodies. B. 
HeLa cells were transiently transfected with GFP-TR (a1 or (31) expression 
plasmids, Myc or Myc-Exp5 (exportin 5) expression plasmids, and tk-TREp-CAT 
reporter plasmids. Twelve hours after adding 100 nM T3, CAT ELISAs were 
performed using whole cell extracts to determine the CAT protein levels. 
Reporter gene expression is measured in ng/mL and determined from CAT 
protein levels by ELISA (n=4). Basal levels of reporter gene expression in HeLa 
cells transiently transfected with GFP-TR (a1 or (31) expression plasmid and 
CAT-Basic Vector expression plasmid showed no CAT protein levels (data not 
shown). Error bars indicate SEMS.
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Figure 9. Proteasome inhibition disrupts nucleocytoplasmic shuttling of 
TRa1. HeLa cells were transiently transfected with GFP-TRa1 expression 
plasmid. FRAP experiments were performed in multinucleated cells in the 
presence or absence of MG132 to monitor the nucleocytoplasmic shuttling of 
GFP-TRa1 (n=4, - MG132; n=4, + MG132). A fluorescence recovery graph 
indicating the shuttling of GFP-TRa1 was generated. Green diamonds represent 
relative fluorescence intensity within unbleached nuclei, while red squares 
represent intensity within bleached nuclei. Error bars indicate SEMs.
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Figure 10. Ubiquitinated TRa1 localizes to the cytoplasm and chromatin.
HeLa cells were transiently transfected with GFP-TRa1 and HA-Ub expression 
plasmids and incubated with MG132 (A) or with MG132 and T3 (B) for 14-16 
hours prior to fractionations. Whole cell extract and fractionations (Cyto: 
cytoplasmic proteins, SN: soluble nuclear proteins, CH: chromatin-bound 
proteins, WC: whole cell proteins) were subject to Western blot analysis. 
Cytoplasmic protein (3-tubulin and nuclear protein (primarily chromatin-bound) 
Histone H3 served as controls to ensure there was no cross-compartment 
contamination in fractionations ((3-tubulin, 55 kDa; H3, 17 kDa). TRa1 was 
immunoprecipated using anti-GFP antibody. The ubiquitinated status of TRa1 
was then analyzed by western blot using anti-HA antibody. TRa1 was degraded 
through the ubiquitin-proteasome pathway. A. With MG132, ubiquitinated 
unliganded TRa1 was localized to the cytoplasm and chromatin. (n=3) B. With 
MG132 and T 3 ,  ubiquitinated liganded TRa1 was localized to primarily the 
chromatin. Whole cell extract from the same experiment is also shown with a 
longer exposure time to show ubiquitinated TR. Whole cells extracts from cells 
transfected with GFP-TRa1 and Myc is used as a control. (n=2)
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Figure 11. A/B domain, Hinge domain, and LBD of TRa1 have potential sites 
for ubiquitination. A. Schematic representation of individual domain constructs 
of TRa1 tagged with GFP-GST-GFP (made by Dr. Mavinakere). B. Domains 1 
(A/B domain), 3 (Hinge domain), and 4 (LBD) have potential lysine residues that 
may be ubiquitinated according to UbPred, an online predictor of potential 
ubiquination sites.
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Figure 12. Ligand-dependent and independent ubiquitination of TRa1 
domains. A. To show that TRa1 is directly ubiquitinated, HeLa cells were 
transfected with GFP-TRa1 expression plasmid and HA-Ub (ubiquitin) or Myc 
expression plasmid and inbucated with DMSO or MG132. Immunoprecipitation 
with anti-GFP antibody was performed with whole cell extracts that were lysed 
after 14-16 hours. Immunopreciptation samples and whole cell extracts were 
subject to Western blot analysis with anti-GFP, anti-HA, anti-(3-tubulin antibodies, 
as an internal control. (n=3) B. To determine which TRa1 domains are 
ubiquitinated, HeLa cells were transiently transfected with GFP-GST-GFP-TRa1 
domain expression plasmids (A/B, DBD, Hinge, LBD) and HA-Ub expression 
plasmid with and without MG132 and T3 for 14-16 hours. Whole cell extracts 
were subject to Western blot analysis after immunoprecipitation with anti-GFP 
antibody. Whole cell extract from HeLa cells transfected with GFP-TRa1 
expression plasmid and Myc was used as a control. (n=2, -T3; n=2, +T3)
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Figure 13. Addition of T4 promotes TRa1 shuttling. HeLa cells were 
transiently transfected with GFP-TRa1 expression plasmid. Cells were incubated 
with 100 nM T3 or 100 nM T4 prior to and during experiments. FRAP was 
performed to monitor the nucleocytoplasmic shuttling of GFP-TRa1 (n=8 , T3; 
n=6 , T4). A fluorescence recovery graph indicating the shuttling of GFP-TRa1 
was generated. Green diamonds represent relative fluorescence intensity within 
unbleached nuclei, while red squares represent intensity within bleached nuclei. 
Error bars indicate SEMs.
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Figure 14. Model of ligand-independent and ligand-dependent TR 
ubiquitination. TRa1 rapidly shuttles in and out of the nucleus in the presence 
or absence of ligand. When TR is not bound to ligand, it can be ubiquitinated in 
the cytoplasm and while bound to chromatin. However, when ligand is present, 
liganded TR is ubiquitinated only while bound to chromatin.
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CHAPTER 3: OTHER EXPERIMENTAL RESULTS
Since TRs can utilize multiple export factors in their nuclear export 
pathway, we sought to inhibit multiple exportins mediating TR shuttling. Parallel 
FRAP experiments utilizing RNAi were performed in the presence of LMB to 
block CRM 1-mediated export. The data from these experiments give rise to 
more questions than answers; and therefore, continued research is needed in 
order to fully understand how inhibiting multiple export pathways impacts protein 
shuttling.
RESULTS
Blocking CRM1 and knocking down exportins do not fully disrupt 
nucleocytoplasmic shuttling of TRa1. TR has multiple NESs characterized in the 
ligand binding domain and can utilize multiple export pathways. To test if nuclear 
export can be completely blocked, we examined the kinetics of TR nuclear export 
when inhibiting both the CRM 1-dependent and CRM 1-independent pathways. 
Since we showed that exportin 5 mediates nuclear export of TRa1, we predicted 
that inhibiting CRM1 with LMB and knocking down exportin 5 would greatly 
disrupt the nucleocytoplasmic shuttling. HeLa cells co-transfected with GFP- 
TRa1 and shRNA expression plasmids (targeting exportin 5, 6, or exportin 5 and 
6) were incubated with LMB prior to and during FRAP experiments.
CRM1 was shown to inhibit nuclear export and re-import of TRa1, 
consistent with previously reported observations by Grespin et al. (2008). 
Recovery of fluorescence to bleached nuclei within live cells transfected with a
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control shRNA in the presence of LMB was 16% (±2%) at 60 min and 40% (±4%) 
at 120 min (Fig. 15). Surprisingly, when inhibiting CRM1 and knocking down 
exportin 5, the kinetics of TRa1 nuclear export were not as slow as when 
blocking CRM1 alone. In the presence of LMB and knockdown of exportin 5, 
recovery of fluorescence to bleached nuclei was measured at 33% (±2%) 
equilibration at 60 min and 53% (±2%) equilibration at 120 min (Fig. 15). 
Compared to knockdown of exportin 5 alone, disrupting both pathways caused a 
markedly slower nuclear export and re-import where fluorescence recovery was 
measured at 60 min and 120 min at 38% (±2%) equilibration and 61% (±3%) 
equilibration. This observation that nuclear export was not completely blocked 
was not expected; parallel experiments were performed to knockdown exportin 6, 
or exportin 5 and 6, as well as inhibiting CRM1. These experiments showed 
similar results with recovery of fluorescence in bleached nuclei equilibrated for 60 
and 120 min at 64% (±4%) and 88% (±5%), respectively for exportin 6 and 30% 
(±3%) and 50% (±3%), respectively for exportin 5 and 6 knockdown (Fig. 15). 
However as expected, knocking down exportin 6 and inhibiting CRM1 did not 
show as great a disruption in nuclear export compared to the other conditions.
Since the kinetics of TRa1 nuclear export were not disrupted as greatly in 
comparison to inhibiting CRM1 alone, we examined how knocking down 
transportin 1, which was shown to not be involved in TR nuclear export, and 
inhibiting CRM1 with LMB would affect shuttling kinetics (Fig. 15). Nuclear 
export kinetics of TRa1 when inhibiting CRM1 and knocking down transportin 1 
was similar to the kinetics when inhibiting CRM1 alone. Fluorescent recovery to
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bleached nuclei equilibrations at 60 and 120 min were measured at 62% (±6%) 
and 76% (±3%) for knocking down transportin 1 (see Fig. 3) while in the 
presence of LMB fluorescence recovery was measured at 16% (±2%) and 40% 
(±4%) for 60 and 120 min , respectively (Fig. 16). When comparing these data 
with exportin 6 knockdown and CRM1 blocked, the kinetics were not the same 
and were markedly slower for transportin 1. This may be due to off-target effects 
of knocking down an exportin in comparison to knocking down a transportin. 
Knocking down exportin gene expression causes no significant effect on Ty 
mediated genes. Since we previously showed that overexpressing exportin 5 
causes a decrease in T3-mediated gene expression, we examined the 
transcriptional activity of GFP-TRa1 when knocking down exportin 5 using a CAT 
reporter under control of a positive TRE. We predicted that knocking down 
exportin 5 would cause an increase in T3-mediated genes since nuclear export of 
TR would be partially inhibited. HeLa cells were transiently transfected with 
GFP-tagged TRa1 expression plasmids, shRNA control or shRNA expression 
plasmid targeting exportin 5, and tk-TREp-CAT reporter plasmids. Twelve hours 
after adding 100 nM T3, CAT ELISAs were performed using whole cell extracts to 
determine CAT protein levels. The levels of CAT protein produced were not 
consistent for each experiment for exportin 5 knockdown. Exportin 5 knockdown 
at the protein level was previously shown to not be as efficient (Fig. 17); this may 
also explain why only a slight increase in CAT protein production was seen. 
These data may also provide evidence that the slight increase in T3-responsive
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gene expression occurs due to another level of transcriptional control not 
accounted for, other than nuclear export.
DISCUSSION
Previously, we showed that TRs have multiple shuttling pathways, CRM1- 
dependent and CRM1-independent (Grespin et al., 2008; Mavinakere et al., 
submitted). In vivo approaches of live cell imaging and FRAP were used to 
inhibit multiple nuclear export pathways at one time to determine how TR 
shuttling was impacted. The CRM 1-mediated nuclear export pathway was 
inhibited with LMB while various exportins were knocked down. From our data, 
we saw that TRa1 shuttling kinetics were not fully disrupted when multiple 
pathways were inhibited. During the first hour of the experiment, 
nucleocytoplasmic shuttling of TRa1 was disrupted similar to the control where 
only CRM1 was inhibited. This observation may be due to off-target effects of 
knocking down exportins since these proteins are essential to cell survival. As 
another control, TR shuttling when transportin 1 was knocked down and CRM1 
inhibited was also examined. The discovery that transportin 1 knockdown and 
CRM1 inhibition caused a similar disruption to CRM1 inhibition alone supports 
that exportin knockdown causes other off-target effects. These data may also 
provide evidence that TRs can be flexible and may utilize other exportins 
available when multiple exportins are not present for nuclear export. TRs have 
multiple NESs, which may aid in ensuring that the protein may still be exported
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from the nucleus. Continued research examining potential off-target effects of 
exportin knockdown and CRM1 inhibition is needed.
We also showed that knocking down exportin 5 does not cause a large 
increase in T3-mediated gene expression. In contrast, we saw that 
overexpressing exportin 5 decreases T3-mediated gene expression. Knocking 
down exportin 5 may not statistically increase T3-mediated gene expression due 
to various reasons. Exportins are important for many macromolecules to be 
translocated out of the nucleus; thus, knockdown of these important proteins may 
cause other downstream effects. Another possiblity is that even though nuclear 
export is reduced, other transcriptional controls are still present within the cell 
that are not accounted for. Another important note to make is that more efficient 
knockdown of exportin 5 is seen when the same protein is overexpressed. 
Continued experiments examining how this more potent knockdown of exportin 5 
affects gene transcription will be critical for further understanding.
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Figure 15. Addition of LMB and knocking down exportins does not completely block 
shuttling of TRa1. HeLa cells were transiently transfected with GFP-TRa1 expression 
plasmid and shRNA expression plasmid targeting exportin 5, exportin 6, or both exportin 5 
and 6 (X5, X6, or X5 & X6). A control shRNA expression plasmid was also used for a control 
where no gene expression knockdown occured. Prior to and during FRAP experiments, cells 
were incubated with LMB. FRAP experiments were performed in multinucleated live cells 
incubated to monitor the movement of GFP-TRa1 from the unbleached to the bleached 
nuclei (n=6, Control shRNA + LMB; n=5, X5 shRNA + LMB; n=8, X6 + LMB; n=6, X5 & X6 
shRNA + LMB). Fluorescence recovery graphs showing the movement of GFP-TR in and 
out of the nucleus were generated with red squares representing the relative intensity within 
bleached nuclei and green diamonds representing the relative intensity within unbleached 
nuclei. Error bars indicate SEMs.
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Figure 2. Addition of LMB when knocking down transportin 1 affects 
shuttling of TRa1 similar to experiments with the addition of LMB when no 
gene expression knockdown occurs. HeLa cells were transiently transfected 
with GFP-TRa1 expression plasmid and shRNA targeting transportin 1 
knockdown (T1). FRAP experiments were performed to monitor the 
nucleoplasmic shuttling of TRa1 (n=5). Fluorescence recovery graph was 
generated with red squares indicating the relative intensity within bleached nuclei 
and green diamonds indicating the relative intensity within unbleached nuclei. 
Error bars indicate SEMs.
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Figure 3. Exportin 5 knockdown slightly increases TR-mediated gene 
expression. HeLa cells were transiently transfected with GFP-TRa1 expression 
plasmids, shRNA expression plasmid (control or targeting exportin 5), and tk- 
TREp-CAT reporter plasmids. Twelve hours after adding 100 nM T3, CAT 
ELISAs were performed using the whole cell extracts to determine the CAT 
protein levels. Reporter gene expression is measured in ng/mL and determined 
from CAT protein levels by ELISA. Basal levels of reporter gene expression in 
HeLa cells transiently transfected with GFP-TRa1 expression plasmid and CAT- 
Basic Vector expression plasmid showed no CAT protein levels (data not 
shown). Error bars indicate SEMS.
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CHAPTER 4: GENERAL DISCUSSION
Research reported in this thesis provides strong evidence that exportins 5 
and 7 play a key role in mediating the CRM 1-independent nuclear export of 
TRa1. While previous research shows that proteasome inhibition blocks TR 
degradation through the ubiquitin proteasome-mediated pathway; we also show 
that proteaseome inhibition blocks TR mobility. These data show a direct 
interaction of ubiquitin with multiple domains of TR. TRa1 can be ubiquitinated in 
the A/B domain and LBD in the presence or absence of T3; however, the DBD 
and Hinge domain can also be ubiquitinated depending on the presence of 
ligand. While T3 promotes more rapid TR degradation, it does not promote more 
rapid nuclear export. In contrast, T4 promotes more rapid nuclear export and re­
import of TR. Interestingly, T3 does impact the localization of ubiquitinated TR.
In the presence of the proteasome inhibitor MG132, ubiquitinated TR 
accumulates in the cytoplasm and chromatin; conversely, with MG132 and T3, 
ubiquitinated TR is primarily chromatin-bound and does not accumulate in the 
cytoplasm. As a whole, this research provides insight into the mechanism and 
physiological significance of TR nuclear export.
FUTURE DIRECTIONS
All FRAP and RNAi coupled experiments were completed in the 
absence of ligand. Even though nuclear export did not change drastically in the 
presence of 100 nM T 3 ,  nuclear export increased when 100 nM T4 was present. 
T3 has been shown to cause a conformational change in TR, primarily in helix 12
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of the ligand binding domain, which also has a NES present. Here, we have 
assumed that the presence of T3 is not changing the NES that may be utilized for 
nuclear export and that any NES within TR is affected with exportin knockdown. 
RNAi and FRAP experiments in the presence of ligand would be an interesting 
approach to answer the question of whether there is a ligand-dependent NES 
changing the exportin utilized in the nuclear export mechanism. Ligand- 
dependent NESs have been seen in other NRs such as GR and VDR (Prufer and 
Barsony, 2002), which would support the potential that TR may behave similarly.
Continued research will also be needed to address protein:protein 
interactions of these exportins with TR in order to identify exportins that directly 
bind this receptor. An in vivo approach using HeLa cells and co- 
immunoprecipitations can be utilized to investigate protein:protein interactions. 
Since protein transport is a transient event, it may be difficult to co- 
immunoprecipiate TR with an export factor; however, use of a Ran-GTP mutant 
unable to hydrolyze to Ran-GDP could promote TR nuclear export and binding to 
export factors. Non-hydrolyzable Ran-GTP inhibits cargo disassembly since 
Ran-GTP promotes export and would enhance the binding of exportins to their 
cargo (Kazgan et al., 2010; Mingot et al., 2004). The benefit of this experiment 
would be that it is performed in vivo and could be continued with future 
experiments examining the conditions needed to promote export complex 
formation. Alternatively, an in vitro approach utilizing pull-down assays can also 
be used to address protein:protein interactions of these exportins with TR.
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This experimental approach examining protein:protein interactions can 
also test what exportins bind particular NESs of TRs. Previously in the lab, two 
CRM 1-independent NESs have been characterized in helix 6 and 12 of the TR 
ligand binding domain (Mavinakere et al., submitted). The same approach 
performing co-immunoprecipitations with HeLa cells transiently transfected with 
the mutant RanQ69L, a nonhydrolyzable Ran, and TRa1 NES mutants (already 
made by Dr. Mavinakere) can be taken. Although it is already known that CRM1 
can bind to a leucine rich NES, it is not known what NES other export factors 
bind. Determining the NES sequences that exportins bind will aid in 
understanding the mechanism by which NR, and other proteins exit the nucleus. 
Also comparing nuclear export kinetics of NES mutant constructs with exportin 5 
and 7 knockdown would be another approach to reveal whether a NES may 
potentially utilize one exportin over another.
Since overexpression of exportin 5 was utilized in this study, it can be 
predicted that overexpressing exportin 7 would also impact TR localization.
Thus, overexpressing exportin 7 to examine TR subcellular distribution, and also 
overexpressing multiple exportins would be interesting to examine to determine if 
TR localization could be completely changed by the presence of multiple 
exportins mediating nuclear export. Investigating whether overexpressing both 
exportin 5 and 7 would cause complete or nearly complete cytoplasmic TR 
localization may be another future direction of this research.
Another focus of this thesis was examining the physiological significance 
of TR nuclear export. Previously, TR ubiquitination and how it impacts nuclear
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export had not been examined extensively; however, researchers reported 
variable results on the impact of ubiquitination on NR nuclear export. As it was 
shown that multiple domains of TRa1 have ubiquitination sites, mutagenesis 
analysis combined with immunoprecipitations would be needed in order to 
determine the exact lysines in TR that are ubiquitinated. These experiments also 
need to be performed in the full length protein since mutliple domains may work 
together to direct ubiquitination of TR. Constructs with multiple TR domains may 
also be used in immunoprecipitations since Dace et al. (2000) showed that the 
LBD is the most important domain needed for TR degradation. These 
immunoprecipitation assays could examine if degradation correlates with 
ubiquitination, since this research shows that any domain may be ubiquitinated. 
Since the understanding of how ubiquitination affects transcription has only 
recently emerged, how ubiquitination impacts TR transcriptional control would 
also be an area of interest for future work. These experiments could utilize a 
CAT ELISA with TR mutants unable to be ubiquitinated and in the presence of 
the proteasome inhibitor MG132 at varying time points. FRAP experiments were 
performed with cells incubated in MG 132 for up to 6 hours; in contrast, cells for 
ubiquitination experiments were incubated in MG132 for over 14 hours. FRAP 
experiments with cells incubated in MG 132 for this time span may be of 
importance in understanding how MG 132 affects TR and ubiquitinated TR 
mobility.
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CONCLUSION
With the discovery that TRs shuttle between the nucleus and cytoplasm, a 
novel mechanism for T3-mediated gene regulation emerged. The observation 
that T3-mediated gene expression is altered when normal TR shuttling is 
disrupted directly supports the importance of shuttling. In addition, when these 
receptors are mutated, they can disrupt homeostasis and promote tumor growth 
and proliferation. While the exact mechanisms of shuttling for NRs in the 
superfamily remain to be elucidated, TRs were previously shown to follow a 
CRM1/calreticulin pathway and other uncharacterized CRM 1-independent 
pathways (Grespin et al., 2009; Mavinakere et al., submitted). Other NRs have 
also been shown to utilize CRM1 and exportin 5, which is a novel export pathway 
for these proteins. Here, we showed that TRs can follow novel export pathways 
mediated by exportin 5 or exportin 7. Further analysis of nuclear export 
pathways and the NES sequences mediating this export will continue to give rise 
to the mechanism involved in T3-mediated gene regulation.
Although this thesis research has shed some light on the significance of 
TR nuclear export, the physiological significance of export is not fully understood. 
Some research has shown that TRs are modified by signals from the cytoplasm, 
which may account for this export (Guigon and Cheng, 2009). For many 
proteins, post-translational modifications have also been shown to affect protein 
localization (Ikeda and Kerppola, 2008; Shank et al., 2008). TRs utilize the 
ubiquitin-proteasome mediated degradation pathway similar to all NRs. Current 
research lacks in the impact of ubiquitination on nuclear export; thus, we focused
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on elucidating where ubiquitinated TR localizes and how it impacts TR export. 
Ubiquitinated TR was found to change subcellular localization when ligand was 
present. Similar to estrogen receptors (Tateishi et al., 2004), this finding 
supports that TRs may be ubiquitinated in two separate locations depending on 
presence of ligand. T3 only slightly slowed nuclear export of TR. Thus, our data 
point to the conclusion that ubiquitination of TR only plays a small role in nuclear 
export.
In conclusion, this thesis research has implications for T3-mediated gene 
regulation at both the level of TR nuclear export and post-translational 
modification. While protein mislocalization is seen in various cancers (Bonamy et 
al., 2005; Bunn et al., 2001), our findings that exportin availability impacts TR 
localization, indicates that additional research is needed in exportin involvement 
in cancer and endocrine disease. Currently, research lacks in exportin-related 
diseases, as they may present themselves as diseases related to their cargo 
mislocalization. Exportin 5 was suggested to be a therapeutic target for shRNA 
delivery (Yi et al, 2005); our research supports that exportin 5 overexpression 
may also create off-target effects where cargo is mislocalized and may cause 
cancer or endocrine disease due to misregulation of T3-mediated genes, or other 
NR-mediated genes. Our research has novel implications for other NR nuclear 
export pathways where exportins 5 and 7 also may be utilized in their as yet 
uncharacterized CRM 1-independent nuclear export pathway. Finally, the 
research presented in this thesis has shed light on the NR export field and has
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implications for how misregulated NR-mediated gene expression may promote 
cancer and other endocrine diseases.
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